{
  "substances": [
    {
      "id": "banned-dmaa",
      "slug": "dmaa",
      "name": "DMAA",
      "alternativeNames": [
        "1,3-Dimethylamylamine",
        "Methylhexanamine",
        "Geranamine",
        "4-Methylhexan-2-amine",
        "1,3-Dimethylpentylamine",
        "Floradrene",
        "Forthane"
      ],
      "category": "stimulant",
      "legalStatus": "banned_usa",
      "legalStatusDetails": "FDA banned DMAA as an unsafe food additive (April 2013). Classified as illegal dietary supplement ingredient. WADA prohibited since 2010. Multiple court challenges (Hi-Tech vs FDA) rejected through Supreme Court (2020).",
      "bannedDate": "2013-04-11",
      "bannedBy": [
        "FDA",
        "WADA",
        "NCAA",
        "NFL",
        "MLB",
        "DoD"
      ],
      "stateRestrictions": {
        "US": "Federal ban - illegal in all dietary supplements",
        "Australia": "Banned - TGA Appendix C (June 2012)",
        "UK": "Banned - MHRA unlicensed medicinal product (August 2012)",
        "Canada": "Banned - classified as drug (2011)",
        "New Zealand": "Banned - Psychoactive Substances Act 2013",
        "Sweden": "Banned",
        "Denmark": "Banned",
        "Finland": "Banned",
        "EU": "Not authorized for food supplements"
      },
      "healthRisks": [
        {
          "category": "Cardiovascular Death",
          "description": "At least 5 documented deaths directly attributed to DMAA, including Claire Squires (London Marathon 2012), PFC Michael Sparling (Fort Bliss 2011), and Sgt Demekia Cola (Fort Bliss 2011).",
          "severity": "severe",
          "sources": ["FDA Adverse Event Database", "UK Coroner Inquest 2013"]
        },
        {
          "category": "Hemorrhagic Stroke",
          "description": "5+ documented cases of intracerebral hemorrhage in users aged 21-41, often within hours of DMAA consumption. BP readings as high as 240/120 mmHg recorded.",
          "severity": "severe",
          "sources": ["PubMed Case Reports", "FDA Warning Letters 2013"]
        },
        {
          "category": "Cardiac Events",
          "description": "Multiple case reports of myocardial infarction, cardiac arrest, and arrhythmias in young, previously healthy individuals.",
          "severity": "high",
          "sources": ["FDA AER Database"]
        },
        {
          "category": "Hypertensive Crisis",
          "description": "Systolic BP increases of 8-16 mmHg at normal doses; case reports show BP as high as 240/120 mmHg in overdose situations.",
          "severity": "high",
          "sources": ["Pharmacokinetic Studies 2013"]
        }
      ],
      "sideEffects": [
        "Hemorrhagic stroke",
        "Cardiac arrest",
        "Myocardial infarction (heart attack)",
        "Hypertensive crisis",
        "Pulmonary edema",
        "Elevated blood pressure (8-16 mmHg increase)",
        "Rapid heartbeat/tachycardia",
        "Seizures",
        "Severe headaches",
        "Tremors and involuntary twitching",
        "Confusion and altered mental status",
        "Liver failure (OxyElite Pro outbreak)",
        "Anxiety and agitation"
      ],
      "contraindications": [
        "Any heart condition or cardiovascular disease",
        "High blood pressure (hypertension)",
        "History of stroke or TIA",
        "Use of other stimulants (caffeine, ephedrine)",
        "Pregnancy or breastfeeding",
        "History of seizures",
        "Liver disease",
        "Use of MAO inhibitors",
        "Alcohol consumption",
        "Physical exertion (especially extreme exercise)",
        "Sexual activity (documented stroke trigger)"
      ],
      "overdoseRisk": "high",
      "addictionPotential": "moderate",
      "description": "DMAA (1,3-dimethylamylamine) is a synthetic sympathomimetic amine originally developed by Eli Lilly in 1944 as a nasal decongestant (Forthane). It gained widespread popularity in pre-workout supplements like Jack3d and OxyElite Pro between 2006-2013, often marketed falsely as 'geranium extract.' Despite manufacturer claims of natural origin, extensive laboratory analysis confirmed DMAA is entirely synthetic. The FDA banned DMAA in 2013 after receiving 86 adverse event reports including at least 5 deaths. Court challenges by Hi-Tech Pharmaceuticals were rejected through the Supreme Court in 2020, definitively establishing DMAA's illegal status.",
      "mechanism": "DMAA is a sympathomimetic amine that primarily functions as a norepinephrine reuptake inhibitor/releasing agent (Ki ~649 nM at NET). It also competitively inhibits the dopamine transporter (DAT) with IC50 ~29.4 µM—approximately 60x less potent than amphetamine. DMAA causes vasoconstriction, elevated blood pressure, and increased heart rate through sympathetic nervous system activation. Unlike amphetamine, DMAA lacks a phenyl ring, which reduces DAT potency but maintains sympathomimetic activity. Terminal half-life is 8.45 hours with minimal hepatic metabolism (>90% excreted unchanged in urine).",
      "history": "1944: Synthesized by Eli Lilly as nasal decongestant. 1948-1983: Marketed as Forthane/Forthan. 1983: Voluntarily withdrawn due to side effects. 2006: Re-emerged in supplements falsely claimed as 'geranium extract.' 2010: WADA prohibition. 2011: Fort Bliss soldier deaths prompt Army investigation. 2012: FDA warning letters to 10+ companies; UK/Australia bans. 2013: FDA declares illegal; USPlabs destroys $8M inventory. 2017-2020: Hi-Tech vs FDA lawsuit rejected through Supreme Court.",
      "whyBanned": "FDA determined DMAA poses unacceptable cardiovascular risks even at recommended doses. Key factors: (1) 5+ documented deaths including young athletes; (2) 86 serious adverse event reports including strokes, heart attacks, and seizures; (3) Synthetic origin despite natural marketing claims; (4) 92.3% of military false positive amphetamine tests caused by DMAA; (5) Hi-Tech vs FDA litigation confirmed DMAA is not a dietary ingredient and lacks safety evidence.",
      "legalAlternatives": [
        "caffeine",
        "citrulline-malate",
        "beta-alanine",
        "l-theanine",
        "alpha-gpc"
      ],
      "metaTitle": "DMAA (1,3-Dimethylamylamine): Complete Guide to the Banned Stimulant [2025]",
      "metaDescription": "Comprehensive guide to DMAA: why it was banned after 5 deaths, how long it stays in your system (8.45 hour half-life, 4-7 day detection), drug test false positives, and safe legal alternatives.",
      "keywords": [
        "what is dmaa",
        "why was dmaa banned",
        "dmaa pre workout",
        "dmaa side effects long term",
        "how long does dmaa stay in your system",
        "dmaa drug test",
        "dmaa false positive",
        "dmaa deaths",
        "1,3-dmaa",
        "methylhexanamine",
        "jack3d banned",
        "dmaa alternative",
        "dmaa legal status 2025"
      ],
      "isPillarPage": true,
      "pillarSections": [
        {
          "id": "what-is-dmaa",
          "title": "What is DMAA?",
          "content": "<p><strong>DMAA (1,3-Dimethylamylamine)</strong> is a synthetic sympathomimetic amine with the chemical formula C₇H₁₇N (molecular weight 115.22 g/mol). Originally developed by Eli Lilly in 1944 as a nasal decongestant under the brand name Forthane, DMAA was voluntarily withdrawn from the pharmaceutical market in 1983 due to side effects.</p><p>In 2006, DMAA re-emerged in dietary supplements marketed as a 'natural' extract from geranium plants. However, extensive scientific analysis by NSF International, the University of Milan, and the FDA definitively established that <strong>DMAA is entirely synthetic</strong>—not derived from any botanical source. The 'geranium extract' claim was fraudulent marketing used to circumvent dietary supplement regulations.</p><p>DMAA gained massive popularity in pre-workout supplements like <strong>Jack3d</strong> and <strong>OxyElite Pro</strong> between 2006-2013 due to its potent stimulant effects, including increased energy, focus, and euphoria. At peak popularity, DMAA-containing products generated hundreds of millions in sales.</p>",
          "keywordTarget": "what is dmaa"
        },
        {
          "id": "why-banned",
          "title": "Why Was DMAA Banned?",
          "content": "<p>The FDA banned DMAA in April 2013 after receiving <strong>86 reports of serious adverse events</strong>, including at least <strong>5 confirmed deaths</strong>. Key reasons for the ban include:</p><ul><li><strong>Deaths:</strong> Claire Squires (30) died during the 2012 London Marathon; PFC Michael Sparling (22) and Sgt Demekia Cola (32) died during training at Fort Bliss in 2011</li><li><strong>Cardiovascular Events:</strong> Multiple heart attacks, strokes, and cardiac arrests in young, healthy individuals</li><li><strong>Hemorrhagic Strokes:</strong> 5+ documented cases of brain hemorrhages in users aged 21-41</li><li><strong>Synthetic Origin:</strong> Laboratory analysis proved DMAA is not a natural botanical ingredient, making it illegal under DSHEA</li><li><strong>Court Confirmation:</strong> Hi-Tech Pharmaceuticals challenged the ban through the Supreme Court (2020)—all appeals were denied, confirming DMAA's illegal status</li></ul><p>In 2013, USPlabs voluntarily destroyed approximately <strong>$8 million</strong> in Jack3d and OxyElite Pro inventory containing DMAA.</p>",
          "keywordTarget": "why was dmaa banned"
        },
        {
          "id": "side-effects-long-term",
          "title": "DMAA Side Effects: Short-Term & Long-Term Risks",
          "content": "<p><strong>Acute (Short-Term) Side Effects:</strong></p><ul><li>Blood pressure elevation: 8-16 mmHg increase (up to 240/120 mmHg in overdose)</li><li>Rapid heartbeat and heart palpitations</li><li>Severe headaches (often prodromal to stroke)</li><li>Tremors and involuntary muscle twitching</li><li>Anxiety, agitation, and restlessness</li><li>Nausea and stomach discomfort</li><li>Excessive sweating</li></ul><p><strong>Severe/Life-Threatening Effects:</strong></p><ul><li><strong>Hemorrhagic stroke:</strong> 5+ documented cases in young users</li><li><strong>Heart attack (myocardial infarction)</strong></li><li><strong>Cardiac arrest</strong></li><li><strong>Seizures</strong></li><li><strong>Acute liver failure</strong> (documented in OxyElite Pro outbreak)</li></ul><p><strong>Long-Term Risks:</strong></p><p>Due to DMAA's ban, long-term studies are limited. However, repeated cardiovascular stress from stimulant abuse can contribute to:</p><ul><li>Chronic hypertension</li><li>Heart muscle damage</li><li>Increased stroke risk</li><li>Potential CYP2D6 enzyme inhibition affecting other medications</li></ul>",
          "keywordTarget": "dmaa pre workout side effects long term"
        },
        {
          "id": "how-long-in-system",
          "title": "How Long Does DMAA Stay in Your System?",
          "content": "<p>DMAA has a <strong>terminal half-life of 8.45 ± 1.9 hours</strong>—meaning it takes about 8.5 hours for half the dose to be eliminated. Key pharmacokinetic data:</p><table><tr><th>Parameter</th><th>Value</th></tr><tr><td>Half-Life</td><td>8.45 hours (range: 6.57-11.79 hours)</td></tr><tr><td>Peak Concentration</td><td>3-5 hours after ingestion</td></tr><tr><td>Volume of Distribution</td><td>236 L (extensive tissue distribution)</td></tr><tr><td>Metabolism</td><td>Minimal—90%+ excreted unchanged in urine</td></tr></table><p><strong>Detection Windows by Test Type:</strong></p><ul><li><strong>Urine:</strong> 4-7 days (up to 105 hours documented)</li><li><strong>Blood:</strong> 24-48 hours</li><li><strong>Hair:</strong> Up to 90 days</li><li><strong>Saliva:</strong> 1-3 days (limited data)</li></ul><p>DMAA's large volume of distribution (236 L) means it accumulates extensively in tissues, contributing to the extended detection window despite moderate clearance rates.</p>",
          "keywordTarget": "how long does dmaa stay in your system"
        },
        {
          "id": "drug-testing",
          "title": "DMAA Drug Testing: False Positives & Detection",
          "content": "<p><strong>Critical Warning:</strong> DMAA causes <strong>false positive results for amphetamines</strong> on standard immunoassay drug tests.</p><p>Military research revealed that <strong>92.3% of false-positive amphetamine samples</strong> in Department of Defense testing contained DMAA. Of 134 false-positive samples analyzed, 124 were caused by DMAA at ~6.0 mg/L concentration.</p><p><strong>Why False Positives Occur:</strong></p><p>Immunoassay screening tests (EMIT) lack specificity and cross-react with DMAA's sympathomimetic structure, flagging it as amphetamine. However, <strong>confirmatory GC-MS testing correctly identifies DMAA</strong> and distinguishes it from actual amphetamines.</p><p><strong>How to Handle a False Positive:</strong></p><ol><li>Request GC-MS confirmatory testing immediately</li><li>Disclose any supplements containing DMAA (or contaminated products)</li><li>Provide supplement labels/receipts as documentation</li><li>Request Medical Review Officer (MRO) evaluation</li></ol><p>The Air Force Drug Testing Laboratory confirms: under GC-MS testing, DMAA will <strong>never</strong> produce a positive result for amphetamines.</p>",
          "keywordTarget": "dmaa drug test false positive"
        },
        {
          "id": "legal-status",
          "title": "DMAA Legal Status by Country (2025)",
          "content": "<table><tr><th>Country</th><th>Status</th><th>Details</th></tr><tr><td>United States</td><td><strong>ILLEGAL</strong></td><td>FDA banned (2013); all court challenges rejected through Supreme Court (2020)</td></tr><tr><td>United Kingdom</td><td><strong>BANNED</strong></td><td>MHRA ruling (August 2012) - unlicensed medicinal product</td></tr><tr><td>Australia</td><td><strong>BANNED</strong></td><td>TGA Appendix C Poisons Standard (June 2012)</td></tr><tr><td>Canada</td><td><strong>BANNED</strong></td><td>Health Canada classified as drug (2011)</td></tr><tr><td>New Zealand</td><td><strong>BANNED</strong></td><td>Psychoactive Substances Act 2013</td></tr><tr><td>European Union</td><td><strong>NOT AUTHORIZED</strong></td><td>Banned in Ireland, Sweden, Denmark, Finland; not approved EU-wide</td></tr><tr><td>WADA</td><td><strong>PROHIBITED</strong></td><td>Banned in all sports since 2010</td></tr><tr><td>U.S. Military</td><td><strong>PROHIBITED</strong></td><td>DoD ban (2012); on Prohibited Dietary Supplement list</td></tr></table>",
          "keywordTarget": "dmaa legal status 2025"
        }
      ],
      "faqs": [
        {
          "question": "Is DMAA legal in 2025?",
          "answer": "No. DMAA is illegal in the United States and banned in most countries including the UK, Australia, Canada, and throughout the EU. The FDA's ban was upheld through the Supreme Court in 2020. Any product containing DMAA is considered an adulterated dietary supplement under federal law."
        },
        {
          "question": "How long does DMAA stay in your system?",
          "answer": "DMAA has a half-life of 8.45 hours. It's detectable in urine for 4-7 days (up to 105 hours with sensitive testing), in blood for 24-48 hours, and in hair for up to 90 days. Over 90% is excreted unchanged in urine."
        },
        {
          "question": "Does DMAA cause false positive drug tests?",
          "answer": "Yes. DMAA causes false positives for amphetamines on immunoassay screening tests. Military data shows 92.3% of false-positive amphetamine samples contained DMAA. However, confirmatory GC-MS testing correctly distinguishes DMAA from amphetamines."
        },
        {
          "question": "Why was DMAA banned?",
          "answer": "The FDA banned DMAA after 86 adverse event reports including at least 5 deaths. Key reasons include documented fatalities in young athletes, hemorrhagic strokes, heart attacks, and proof that DMAA is synthetic (not natural geranium extract as marketed)."
        },
        {
          "question": "What are safe legal alternatives to DMAA?",
          "answer": "Legal alternatives include caffeine (for energy), citrulline malate (for pumps and performance), beta-alanine (for endurance), and L-theanine combined with caffeine (for focused energy without jitters). These ingredients are FDA-compliant with established safety profiles."
        },
        {
          "question": "Can DMAA cause a stroke?",
          "answer": "Yes. There are at least 5 documented cases of hemorrhagic stroke (brain bleeding) in DMAA users aged 21-41. DMAA causes severe blood pressure elevation—readings as high as 240/120 mmHg have been documented in overdose cases."
        }
      ],
      "citations": [
        {
          "title": "Pharmacokinetics of 1,3-dimethylamylamine and caffeine after administration of the dietary supplement",
          "url": "https://pubmed.ncbi.nlm.nih.gov/24090077/",
          "source": "PubMed",
          "year": "2013"
        },
        {
          "title": "FDA Information on DMAA",
          "url": "https://www.fda.gov/food/dietary-supplement-ingredient-directory/dmaa-products-marketed-dietary-supplements",
          "source": "FDA",
          "year": "2013"
        },
        {
          "title": "DMAA in Products Marketed as Dietary Supplements",
          "url": "https://www.fda.gov/food/information-select-dietary-supplement-ingredients-and-other-substances/dmaa-products-marketed-dietary-supplements",
          "source": "FDA",
          "year": "2013"
        },
        {
          "title": "OPSS DMAA Fact Sheet",
          "url": "https://www.opss.org/article/dmaa-prohibited-stimulant",
          "source": "DoD OPSS",
          "year": "2023"
        }
      ],
      "relatedPages": [
        {
          "slug": "banned-pre-workouts-2025",
          "title": "Complete List of Banned Pre Workouts 2025",
          "type": "article",
          "relationship": "cluster"
        },
        {
          "slug": "dmaa-drug-testing-guide",
          "title": "DMAA Drug Testing: False Positives & How to Dispute",
          "type": "article",
          "relationship": "cluster"
        },
        {
          "slug": "dark-labs-crack-gold",
          "title": "Dark Labs Crack Gold 2025 Review",
          "type": "banned",
          "relationship": "cluster"
        },
        {
          "slug": "skull-labs-angel-dust",
          "title": "Skull Labs Angel Dust Ingredients",
          "type": "banned",
          "relationship": "cluster"
        },
        {
          "slug": "dmha",
          "title": "DMHA (Octodrine)",
          "type": "banned",
          "relationship": "related"
        }
      ],
      "createdAt": "2025-01-01T00:00:00Z",
      "updatedAt": "2025-11-28T00:00:00Z"
    },
    {
      "id": "banned-phenibut",
      "slug": "phenibut",
      "name": "Phenibut",
      "alternativeNames": [
        "4-Amino-3-phenylbutanoic acid",
        "Phenyl-GABA",
        "β-Phenyl-γ-aminobutyric acid",
        "Fenibut",
        "Noofen",
        "Citrocard"
      ],
      "category": "nootropic",
      "legalStatus": "banned_usa",
      "legalStatusDetails": "Banned as dietary supplement ingredient (April 2019). Schedule II in Alabama. Sold only as 'research chemical' online.",
      "bannedDate": "2019-04-01",
      "bannedBy": [
        "FDA"
      ],
      "stateRestrictions": {
        "Alabama": "Schedule II controlled substance",
        "Kentucky": "Controlled substance restrictions",
        "Australia": "Schedule 9 prohibited substance (Feb 2018)",
        "France": "Banned",
        "Germany": "Banned",
        "UK": "Unlicensed - cannot be sold",
        "Italy": "Banned"
      },
      "healthRisks": [
        {
          "category": "Overdose/Poisoning",
          "description": "1,320 poison center cases reported (2009-2019), sharp increase 2015-2019. 3 deaths, 80 comas documented.",
          "severity": "high",
          "sources": [
            "American Association of Poison Control Centers"
          ]
        },
        {
          "category": "Withdrawal",
          "description": "Severe withdrawal syndrome similar to alcohol/benzodiazepine withdrawal - can cause seizures, psychosis, and death.",
          "severity": "high",
          "sources": [
            "FDA Safety Alert 2019",
            "2024 Systematic Review (15 cases)"
          ]
        },
        {
          "category": "Dependence",
          "description": "Physical dependence can develop in as little as 2-3 weeks of daily use at doses over 1g/day.",
          "severity": "high",
          "sources": [
            "PubMed Case Reports"
          ]
        }
      ],
      "sideEffects": [
        "Agitation and severe anxiety",
        "Tachycardia and hypertension",
        "Drowsiness and sedation",
        "Severe withdrawal syndrome",
        "Respiratory depression",
        "Visual and auditory hallucinations",
        "Seizures",
        "Psychosis and delusions",
        "Tremor and myoclonus",
        "Insomnia (rebound)"
      ],
      "contraindications": [
        "History of substance abuse",
        "CNS depressant use (alcohol, benzodiazepines, opioids)",
        "Pregnancy and breastfeeding",
        "Kidney disease (renally excreted)",
        "Psychiatric conditions",
        "Seizure history"
      ],
      "overdoseRisk": "high",
      "addictionPotential": "high",
      "description": "Phenibut (β-Phenyl-γ-aminobutyric acid) is a synthetic GABA analogue developed in the Soviet Union that acts primarily as a GABA-B receptor agonist. It produces anxiolytic and sedative effects but carries extremely high risks of dependence and a severe, potentially life-threatening withdrawal syndrome similar to alcohol or benzodiazepine withdrawal.",
      "mechanism": "Acts as a GABA-B receptor agonist and α2δ voltage-gated calcium channel ligand. The phenyl ring allows it to cross the blood-brain barrier more efficiently than GABA itself. Also binds α2δ subunit similar to gabapentin. Plasma half-life approximately 5.3 hours, but effects last 15-24 hours.",
      "history": "Developed in the Soviet Union (Leningrad) in the 1960s as a neuropsychotropic agent for cosmonauts to manage stress and anxiety without impairing cognitive function. Still used as a prescription medicine in Russia, Ukraine, and Latvia under names like Noofen and Citrocard. Never approved for medical use in Western countries.",
      "whyBanned": "FDA issued warning letters in April 2019 determining phenibut does not meet the statutory definition of a dietary ingredient. The severe risk of dependence, potentially fatal withdrawal syndrome (with seizures and psychosis), and lack of proven efficacy led to its effective ban from dietary supplements. It's now only sold illegally as a 'research chemical.'",
      "legalAlternatives": [
        "l-theanine",
        "ashwagandha",
        "magnesium-glycinate"
      ],
      "isPillarPage": true,
      "pillarSections": [
        {
          "id": "what-is-phenibut",
          "title": "What is Phenibut? Soviet Origins & How It Works",
          "content": "<p><strong>Phenibut (β-Phenyl-γ-aminobutyric acid)</strong> is a synthetic derivative of the inhibitory neurotransmitter GABA, developed in the Soviet Union in the 1960s. Unlike GABA itself, phenibut's phenyl ring allows it to cross the blood-brain barrier efficiently.</p><h3>How Phenibut Works in the Brain</h3><p>Phenibut acts through two primary mechanisms:</p><ul><li><strong>GABA-B Receptor Agonism:</strong> Produces anxiolytic (anti-anxiety) and sedative effects similar to baclofen and GHB</li><li><strong>α2δ Calcium Channel Binding:</strong> Similar to gabapentin/pregabalin, contributing to its calming effects</li></ul><p>The R-isomer of phenibut has approximately <strong>5-fold higher affinity for α2δ</strong> than for GABA-B receptors, making its mechanism more complex than simple GABA enhancement.</p><h3>Pharmacokinetics</h3><table><thead><tr><th>Parameter</th><th>Value</th></tr></thead><tbody><tr><td>Plasma Half-Life</td><td>~5.3 hours</td></tr><tr><td>Duration of Effects</td><td>15-24 hours (subjective)</td></tr><tr><td>Brain Penetration</td><td>~0.1% of dose reaches brain</td></tr><tr><td>Excretion</td><td>63-65% unchanged in urine</td></tr></tbody></table><p><strong>Warning:</strong> Despite the relatively short half-life, phenibut's effects persist much longer than plasma levels suggest, and dependence develops rapidly with daily use.</p>",
          "keywordTarget": "what is phenibut"
        },
        {
          "id": "why-banned",
          "title": "Why FDA Banned Phenibut (2019 Warning Letters)",
          "content": "<p>On <strong>April 10-16, 2019</strong>, the FDA issued warning letters to multiple companies marketing products containing phenibut as dietary supplements, effectively banning it from the legitimate supplement market.</p><h3>FDA's Legal Determination</h3><p>The FDA determined that phenibut:</p><ul><li><strong>Does not meet the statutory definition</strong> of a dietary ingredient under the Federal Food, Drug, and Cosmetic Act</li><li>Products containing phenibut are <strong>adulterated and misbranded</strong></li><li>Has <strong>no recognized medical use</strong> in the United States</li><li>Poses serious safety risks including <strong>dependence and life-threatening withdrawal</strong></li></ul><h3>Enforcement Actions</h3><p>FDA warning letters were sent to companies including:</p><ul><li>American Made Nutrition LLC</li><li>Bulk Stimulants</li><li>SL Nutrition, Inc.</li><li>Various online retailers</li></ul><p>Following FDA action, major retailers removed phenibut products. However, it remains available from 'research chemical' vendors operating in a legal gray area.</p><h3>State-Level Actions</h3><table><thead><tr><th>State</th><th>Status</th></tr></thead><tbody><tr><td>Alabama</td><td>Schedule II Controlled Substance</td></tr><tr><td>Kentucky</td><td>Controlled substance restrictions</td></tr></tbody></table><p>More states are expected to schedule phenibut as awareness of its dangers grows.</p>",
          "keywordTarget": "phenibut FDA ban 2019"
        },
        {
          "id": "withdrawal-syndrome",
          "title": "Phenibut Withdrawal Syndrome: Symptoms & Severity",
          "content": "<p><strong>Phenibut withdrawal is a medical emergency</strong> that can be life-threatening. The syndrome resembles severe alcohol or benzodiazepine withdrawal, with documented cases of seizures, psychosis, and deaths.</p><h3>Withdrawal Timeline</h3><table><thead><tr><th>Phase</th><th>Timeline</th><th>Key Symptoms</th></tr></thead><tbody><tr><td>Early</td><td>2-24 hours</td><td>Anxiety, tremor, palpitations, insomnia, sweating</td></tr><tr><td>Acute Peak</td><td>Days 1-3</td><td>Severe anxiety, psychosis, hallucinations, seizures, autonomic instability</td></tr><tr><td>Subacute</td><td>Days 4-14</td><td>Persistent insomnia, anxiety waves, depression, cognitive fog</td></tr><tr><td>Protracted (PAWS)</td><td>Weeks to months</td><td>Intermittent anxiety, sleep disruption, mood instability</td></tr></tbody></table><h3>Most Dangerous Symptoms</h3><ul><li><strong>Seizures:</strong> Generalized tonic-clonic seizures can occur, especially with abrupt cessation</li><li><strong>Psychosis:</strong> Visual/auditory hallucinations, paranoid delusions, inability to recognize reality</li><li><strong>Autonomic Instability:</strong> Severe tachycardia, hypertension, fever, diaphoresis</li><li><strong>Suicidal Ideation:</strong> Profound dysphoria and hopelessness</li></ul><h3>2024 Systematic Review Findings</h3><p>A comprehensive review of 15 documented phenibut withdrawal cases found:</p><ul><li>Doses ranged from 1g/day to over 30g/day</li><li>Duration of use from 2 weeks to several years</li><li>Most required hospitalization, some in ICU</li><li><strong>92.3% presented with psychomotor agitation</strong></li></ul><p><strong>Never stop phenibut cold turkey.</strong> Abrupt cessation from daily use can trigger life-threatening withdrawal.</p>",
          "keywordTarget": "phenibut withdrawal symptoms"
        },
        {
          "id": "detection-testing",
          "title": "Phenibut Drug Testing & Detection Windows",
          "content": "<p>Phenibut is <strong>not detected on standard drug tests</strong> including typical employment and clinical screening panels. However, specialized testing can identify it.</p><h3>Detection Methods</h3><table><thead><tr><th>Test Type</th><th>Detects Phenibut?</th><th>Notes</th></tr></thead><tbody><tr><td>Standard Urine Panel (5/10/12)</td><td>No</td><td>Tests for opioids, benzos, THC, cocaine, etc.</td></tr><tr><td>Immunoassay Screening</td><td>No</td><td>No cross-reactivity with tested substances</td></tr><tr><td>LC-MS/MS (specialized)</td><td>Yes</td><td>Requires specific order, forensic/toxicology labs</td></tr><tr><td>GC-MS (specialized)</td><td>Yes</td><td>Gold standard confirmation method</td></tr></tbody></table><h3>Detection Windows</h3><p>Based on phenibut's pharmacokinetics (5.3-hour half-life, renal excretion):</p><ul><li><strong>Blood:</strong> 24-48 hours after typical doses</li><li><strong>Urine:</strong> 1-2 days after therapeutic doses; potentially longer with chronic heavy use</li><li><strong>Hair:</strong> Theoretically detectable but rarely tested</li></ul><h3>When Testing May Occur</h3><p>Specialized phenibut testing may be ordered in:</p><ul><li>Emergency departments when phenibut use is suspected</li><li>Addiction treatment intake assessments</li><li>Forensic toxicology investigations</li><li>Research studies on GABAergic substances</li></ul><p><strong>Important:</strong> Even though phenibut won't trigger a standard drug test, its withdrawal can be medically dangerous. Be honest with healthcare providers about use.</p>",
          "keywordTarget": "phenibut drug test detection"
        },
        {
          "id": "legal-status-2025",
          "title": "Phenibut Legal Status 2025: US & International",
          "content": "<h3>United States Federal Status (2025)</h3><p>Phenibut occupies a <strong>legal gray area</strong> at the federal level:</p><ul><li><strong>Not FDA-approved</strong> as a drug or dietary supplement ingredient</li><li><strong>Not scheduled</strong> under the Controlled Substances Act (possession is not federally criminal)</li><li><strong>Cannot be legally sold</strong> as a dietary supplement (per 2019 FDA determination)</li><li>Available only as a 'research chemical' from specialty vendors</li></ul><h3>State-Level Restrictions</h3><table><thead><tr><th>State</th><th>Status</th><th>Details</th></tr></thead><tbody><tr><td>Alabama</td><td>Schedule II</td><td>Controlled substance since 2021; possession without prescription is illegal</td></tr><tr><td>Kentucky</td><td>Restricted</td><td>Controlled substance restrictions apply</td></tr><tr><td>Other States</td><td>Legal but unregulated</td><td>No specific state laws, but FDA rules still apply to sellers</td></tr></tbody></table><h3>International Legal Status</h3><table><thead><tr><th>Country/Region</th><th>Status</th></tr></thead><tbody><tr><td>Russia/Ukraine/Latvia</td><td>Prescription medicine (Noofen, Citrocard)</td></tr><tr><td>Australia</td><td>Schedule 9 Prohibited Substance (Feb 2018)</td></tr><tr><td>United Kingdom</td><td>Unlicensed; cannot be legally sold as supplement</td></tr><tr><td>France/Germany/Italy</td><td>Banned from sale</td></tr><tr><td>Canada</td><td>Unscheduled but not approved as natural health product</td></tr></tbody></table><p><strong>2025 Outlook:</strong> More US states are expected to schedule phenibut as awareness of its dangers increases. Federal scheduling remains possible if abuse cases continue to rise.</p>",
          "keywordTarget": "is phenibut legal 2025"
        },
        {
          "id": "safe-alternatives",
          "title": "Safe Legal Alternatives to Phenibut",
          "content": "<p>If you're seeking anxiety relief or better sleep without phenibut's dangerous dependency risks, these <strong>evidence-based alternatives</strong> are legal and much safer:</p><h3>For Anxiety</h3><h4>1. L-Theanine</h4><ul><li><strong>Mechanism:</strong> Amino acid from tea that increases alpha-wave activity and modulates glutamate/GABA</li><li><strong>Evidence:</strong> Clinical trials show reduced physiological and subjective stress; 400mg/day effective for anxiety</li><li><strong>Safety:</strong> Well-tolerated up to 900mg/day with minimal side effects</li><li><strong>Dosage:</strong> 100-400mg daily</li></ul><h4>2. Ashwagandha (Withania somnifera)</h4><ul><li><strong>Mechanism:</strong> Adaptogenic herb that modulates cortisol and HPA-axis activity</li><li><strong>Evidence:</strong> Multiple RCTs show significant anxiety and stress reduction at 300-600mg/day</li><li><strong>Safety:</strong> Generally well-tolerated; avoid in pregnancy and autoimmune conditions</li><li><strong>Dosage:</strong> 300-600mg standardized extract daily</li></ul><h3>For Sleep</h3><h4>3. Magnesium Glycinate</h4><ul><li><strong>Mechanism:</strong> Essential mineral that modulates GABA signaling and is required for serotonin synthesis</li><li><strong>Evidence:</strong> 2025 RCT showed improved insomnia scores within 2 weeks at 250mg elemental magnesium</li><li><strong>Safety:</strong> Safe for most; avoid high doses with kidney disease</li><li><strong>Dosage:</strong> 200-400mg elemental magnesium before bed</li></ul><h4>4. Glycine</h4><ul><li><strong>Mechanism:</strong> Inhibitory amino acid that lowers core body temperature and promotes sleep</li><li><strong>Evidence:</strong> RCTs show 3g before bed improves sleep quality and reduces next-day fatigue</li><li><strong>Safety:</strong> Well-tolerated with no dependence risk</li></ul><h3>When to Seek Medical Help</h3><p>If you have persistent anxiety lasting weeks, significant daily impairment, or history of substance use, consult a physician. Prescription options like SSRIs/SNRIs may be more appropriate than supplements.</p>",
          "keywordTarget": "phenibut legal alternatives"
        }
      ],
      "faqs": [
        {
          "question": "How long does phenibut withdrawal last?",
          "answer": "Acute phenibut withdrawal typically peaks within 1-3 days and improves over 1-2 weeks with treatment. However, protracted withdrawal symptoms (PAWS) including anxiety, insomnia, and mood instability can persist for weeks to months, especially after heavy or prolonged use. The 2024 systematic review found most cases resolved within 5-14 days with medical management."
        },
        {
          "question": "Can phenibut withdrawal cause seizures?",
          "answer": "Yes, phenibut withdrawal can cause life-threatening seizures, especially with abrupt cessation after daily use. The mechanism is similar to alcohol or benzodiazepine withdrawal - sudden removal of GABAergic activity leads to CNS hyperexcitability. This is why medical supervision and gradual tapering are essential. Never stop phenibut cold turkey."
        },
        {
          "question": "Is phenibut legal in the United States?",
          "answer": "Phenibut is in a legal gray area in the US. It's not federally scheduled (possession isn't criminal), but the FDA determined in 2019 that it cannot be legally sold as a dietary supplement. It's only available as a 'research chemical.' Alabama has scheduled it as a controlled substance, and other states may follow."
        },
        {
          "question": "Does phenibut show up on a drug test?",
          "answer": "No, phenibut is not detected on standard drug tests including 5-panel, 10-panel, and 12-panel urine screens. It requires specialized testing (LC-MS/MS or GC-MS) that is only available at forensic or specialized toxicology laboratories and must be specifically ordered."
        },
        {
          "question": "How do you safely taper off phenibut?",
          "answer": "Safe phenibut tapering typically involves reducing doses by 50-100mg (5-10%) every 1-2 weeks, with slower reductions as doses get lower. Many clinicians prefer cross-tapering to baclofen (approximately 10mg baclofen per 1g phenibut) which can then be tapered more controllably. Always consult a physician experienced with GABAergic withdrawal."
        },
        {
          "question": "What does phenibut withdrawal feel like?",
          "answer": "Phenibut withdrawal typically causes severe anxiety, insomnia, tremor, rapid heartbeat, sweating, and agitation. In severe cases, it can cause visual and auditory hallucinations, psychosis, paranoid delusions, and seizures. Many describe it as one of the worst withdrawal experiences, comparable to severe alcohol or benzodiazepine withdrawal."
        },
        {
          "question": "Can you die from phenibut withdrawal?",
          "answer": "Yes, phenibut withdrawal can be fatal. Deaths have occurred from seizures, aspiration during psychosis, self-harm during severe dysphoria, and cardiovascular complications from autonomic instability. This is why phenibut withdrawal should be treated as a medical emergency and never attempted without professional supervision."
        },
        {
          "question": "Why is phenibut so addictive?",
          "answer": "Phenibut is highly addictive because it acts on GABA-B receptors (similar to alcohol and GHB) and tolerance develops rapidly - often within 2-3 weeks of daily use. Users need increasing doses to achieve the same effect, and the brain becomes dependent on phenibut to maintain normal GABAergic function. Stopping triggers severe rebound anxiety and physical withdrawal."
        },
        {
          "question": "What is the best natural alternative to phenibut?",
          "answer": "The best evidence-based alternatives are L-theanine (100-400mg) for daytime anxiety, ashwagandha (300-600mg) for stress reduction, and magnesium glycinate (200-400mg) for sleep. These have clinical evidence for efficacy without the severe dependence and withdrawal risks of phenibut. For significant anxiety, consult a physician about prescription options."
        },
        {
          "question": "How quickly can you become dependent on phenibut?",
          "answer": "Physical dependence on phenibut can develop in as little as 2-3 weeks of daily use, especially at doses above 1g/day. Tolerance often develops within the first week, leading to dose escalation. Case reports document severe withdrawal in users who took phenibut for only 2 weeks. The dependence liability is significantly higher than most OTC supplements."
        }
      ],
      "citations": [
        {
          "title": "Phenibut (β-phenyl-γ-aminobutyric acid): A Review of Clinical Efficacy and Safety",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC6535394/",
          "source": "PMC",
          "year": "2019"
        },
        {
          "title": "Systematic Review of Phenibut Withdrawal Cases",
          "url": "https://pubmed.ncbi.nlm.nih.gov/38112312/",
          "source": "PubMed",
          "year": "2024"
        },
        {
          "title": "Phenibut Dependence and Management of Withdrawal",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC5662439/",
          "source": "PMC",
          "year": "2017"
        },
        {
          "title": "FDA Warning Letters: Products Containing Phenibut",
          "url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/american-made-nutrition-llc-575469-04102019",
          "source": "FDA",
          "year": "2019"
        },
        {
          "title": "Phenibut Withdrawal: A Systematic Review of Case Reports",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10323501/",
          "source": "PMC",
          "year": "2023"
        },
        {
          "title": "Phenibut-Related Deaths: A Case Series",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC8647977/",
          "source": "PMC",
          "year": "2021"
        },
        {
          "title": "Baclofen for Phenibut Withdrawal: Case Reports",
          "url": "https://casereports.bmj.com/content/casereports/2013/bcr-2012-008381.full.pdf",
          "source": "BMJ Case Reports",
          "year": "2013"
        },
        {
          "title": "Phenibut Psychosis and Withdrawal",
          "url": "https://www.frontiersin.org/journals/psychiatry/articles/10.3389/fpsyt.2021.688147/full",
          "source": "Frontiers in Psychiatry",
          "year": "2021"
        },
        {
          "title": "GABA-B Receptor Pharmacology of Phenibut",
          "url": "https://pubmed.ncbi.nlm.nih.gov/11830761/",
          "source": "PubMed",
          "year": "2002"
        },
        {
          "title": "American Association of Poison Control Centers: Phenibut Exposures",
          "url": "https://aapcc.org/",
          "source": "AAPCC",
          "year": "2019"
        },
        {
          "title": "Australian Scheduling of Phenibut (Schedule 9)",
          "url": "https://www.tga.gov.au/scheduling-decision-final/phenibut",
          "source": "TGA",
          "year": "2018"
        },
        {
          "title": "Noofen (Phenibut) Product Information - Latvia",
          "url": "https://www.olainfarm.com/products/noofen/",
          "source": "Olainfarm",
          "year": "2023"
        },
        {
          "title": "L-Theanine for Anxiety: Systematic Review",
          "url": "https://pubmed.ncbi.nlm.nih.gov/31758301/",
          "source": "PubMed",
          "year": "2019"
        },
        {
          "title": "Ashwagandha for Stress and Anxiety: Meta-Analysis",
          "url": "https://pubmed.ncbi.nlm.nih.gov/32818573/",
          "source": "PubMed",
          "year": "2020"
        },
        {
          "title": "Magnesium Supplementation for Insomnia",
          "url": "https://pubmed.ncbi.nlm.nih.gov/35184264/",
          "source": "PubMed",
          "year": "2022"
        }
      ],
      "relatedPages": [
        {
          "slug": "phenibut-taper-schedule",
          "title": "Safe Phenibut Tapering Schedule Guide",
          "type": "article",
          "relationship": "cluster"
        },
        {
          "slug": "phenibut-paws-recovery-timeline",
          "title": "Phenibut Withdrawal Timeline & PAWS Recovery",
          "type": "article",
          "relationship": "cluster"
        },
        {
          "slug": "phenibut-withdrawal-warning-signs",
          "title": "Phenibut Withdrawal Warning Signs: When to Seek Help",
          "type": "article",
          "relationship": "cluster"
        },
        {
          "slug": "phenibut-baclofen-taper",
          "title": "Phenibut to Baclofen Taper Protocol",
          "type": "article",
          "relationship": "cluster"
        },
        {
          "slug": "phenibut-natural-withdrawal-support",
          "title": "Natural Phenibut Withdrawal Support",
          "type": "article",
          "relationship": "cluster"
        },
        {
          "slug": "l-theanine",
          "title": "L-Theanine: Safe Anxiety Alternative",
          "type": "supplement",
          "relationship": "related"
        },
        {
          "slug": "ashwagandha",
          "title": "Ashwagandha: Natural Stress Support",
          "type": "supplement",
          "relationship": "related"
        },
        {
          "slug": "magnesium-glycinate",
          "title": "Magnesium Glycinate: Sleep & Relaxation",
          "type": "supplement",
          "relationship": "related"
        }
      ],
      "metaTitle": "Phenibut: Complete Guide to the Banned Nootropic - Withdrawal, Legal Status & Alternatives [2025]",
      "metaDescription": "Comprehensive guide to Phenibut: why FDA banned it, severe withdrawal risks (seizures, psychosis), state-by-state legal status, and safe legal alternatives.",
      "keywords": [
        "phenibut",
        "phenibut ban",
        "phenibut withdrawal",
        "phenibut withdrawal symptoms",
        "phenibut taper",
        "phenibut legal status",
        "is phenibut legal",
        "phenibut alternative",
        "phenibut dangers",
        "phenibut seizure",
        "phenibut psychosis",
        "phenibut dependence",
        "phenibut detox",
        "gaba supplement"
      ],
      "createdAt": "2025-01-01T00:00:00Z",
      "updatedAt": "2025-11-28T00:00:00Z"
    },
    {
      "id": "banned-kratom",
      "slug": "kratom",
      "name": "Kratom",
      "alternativeNames": [
        "Mitragyna speciosa",
        "Ketum",
        "Kakuam",
        "Thang",
        "Biak-Biak",
        "Thom"
      ],
      "category": "opioid",
      "legalStatus": "restricted",
      "legalStatusDetails": "Not federally scheduled but under FDA Import Alert 54-15. Banned in 7 states including the 2025 Louisiana Ban (SB 154, effective Aug 1, 2025). Texas Regulation (SB 1868, effective Sept 1, 2025) imposes the nation's strictest 7-OH limits at 0.1%. FDA recommended scheduling 7-hydroxymitragynine (7-OH) in July 2025. 15+ states have adopted the Kratom Consumer Protection Act (KCPA) with age restrictions and testing requirements.",
      "bannedBy": [
        "FDA (Import Alert 54-15)",
        "Alabama",
        "Arkansas",
        "Indiana",
        "Rhode Island",
        "Vermont",
        "Wisconsin",
        "Louisiana (SB 154)"
      ],
      "stateRestrictions": {
        "Alabama": "Schedule I - Fully Banned (May 2016)",
        "Arkansas": "Schedule I - Fully Banned (2016)",
        "Indiana": "Fully Banned (2014)",
        "Rhode Island": "Schedule I - Fully Banned (2017)",
        "Vermont": "Schedule I - Fully Banned (2016)",
        "Wisconsin": "Schedule I - Fully Banned (2014)",
        "Louisiana": "Schedule I - SB 154 Ban (Aug 1, 2025) - $50K fine, 1-5 years for distribution",
        "Texas": "KCPA - SB 1868 (Sept 1, 2025) - Strictest 7-OH limit at 0.1%, age 21+",
        "Georgia": "KCPA - HB 181 (Jan 1, 2025) - Age 21+, strict labeling",
        "Arizona": "KCPA - Age 21+ (Jan 1, 2025)",
        "Florida": "KCPA - Age 21+, Sarasota County banned",
        "Colorado": "Age 21+, candy/vape forms banned",
        "Oklahoma": "KCPA - SB 891 (2025) - Age 18+, max 2% 7-OH",
        "South Carolina": "KCPA - SB 221 (July 2025)",
        "Connecticut": "Pending Schedule I - hearing Oct 2025"
      },
      "healthRisks": [
        {
          "category": "Overdose Deaths",
          "description": "CDC documented 91 overdose deaths involving kratom (2016-2017). Most cases involved other substances, but kratom was the sole toxicological finding in some fatalities.",
          "severity": "high",
          "sources": ["CDC MMWR Report 2019"]
        },
        {
          "category": "Opioid Dependence",
          "description": "Mitragynine and 7-hydroxymitragynine act on mu-opioid receptors, creating physical dependence. Withdrawal symptoms include muscle aches, insomnia, irritability, and anxiety lasting 4-10 days.",
          "severity": "high",
          "sources": ["PMC Withdrawal Studies 2023"]
        },
        {
          "category": "Seizure Risk",
          "description": "Analysis of Poison Control data (2011-2017) identified 113 kratom-induced seizures. Risk increases with concentrated 7-OH products.",
          "severity": "high",
          "sources": ["Neurology Journal 2025"]
        },
        {
          "category": "Contamination",
          "description": "199 people infected in 2018 Salmonella outbreak linked to kratom. Products often contaminated with bacteria, heavy metals, and in some cases synthetic opioids.",
          "severity": "moderate",
          "sources": ["CDC Outbreak Report 2018"]
        },
        {
          "category": "Hepatotoxicity",
          "description": "Rare cases of liver injury documented in chronic users. Mechanism may involve CYP enzyme inhibition or direct hepatocellular toxicity.",
          "severity": "moderate",
          "sources": ["FDA Adverse Event Reports"]
        }
      ],
      "sideEffects": [
        "Opioid-like withdrawal syndrome (muscle aches, insomnia, RLS)",
        "Nausea, vomiting, and constipation",
        "Seizures (especially with high doses or 7-OH products)",
        "Liver toxicity (rare but documented)",
        "Rapid tolerance development requiring dose escalation",
        "Anxiety, irritability, and mood swings",
        "Weight loss and appetite suppression",
        "Dry mouth and dehydration",
        "Cardiovascular effects at high doses"
      ],
      "contraindications": [
        "History of opioid use disorder",
        "Liver disease or elevated liver enzymes",
        "Pregnancy or breastfeeding",
        "Concurrent use of CNS depressants (benzos, alcohol, opioids)",
        "History of seizures",
        "MAO inhibitor use",
        "Kidney disease"
      ],
      "overdoseRisk": "high",
      "addictionPotential": "high",
      "description": "Kratom (Mitragyna speciosa) is a tropical evergreen tree native to Southeast Asia whose leaves contain alkaloids that act on opioid receptors. The two primary alkaloids—mitragynine and 7-hydroxymitragynine (7-OH)—produce dose-dependent effects: stimulation at low doses (1-5g) and sedation/analgesia at higher doses (5-15g). While marketed as a 'natural' alternative to opioids, kratom produces physiological dependence with a documented withdrawal syndrome. The FDA maintains Import Alert 54-15 and has not approved kratom for any medical use.",
      "mechanism": "Mitragynine is a partial agonist at mu-opioid receptors with additional activity at kappa, delta opioid receptors, alpha-2 adrenergic receptors, and serotonergic systems. 7-hydroxymitragynine is approximately 22x more potent at mu-opioid receptors. This multi-receptor activity explains kratom's unique combination of stimulant (low dose) and sedative (high dose) effects, as well as its complex withdrawal presentation combining opioid-like and stimulant-like features.",
      "history": "Traditional use in Thailand and Malaysia for centuries as a labor aid and folk medicine. Thailand banned kratom in 1943 due to interference with opium tax revenue, then decriminalized it in 2021. In the US, kratom gained popularity in the 2010s as an alternative to prescription opioids. The DEA attempted emergency Schedule I classification in 2016 but withdrew after unprecedented public backlash. Multiple contamination outbreaks, overdose deaths, and wrongful death lawsuits have driven increasing state-level regulation.",
      "whyBanned": "States ban kratom due to: (1) Opioid-like addiction and withdrawal potential; (2) 91+ documented deaths involving kratom; (3) Contamination issues including the 2018 Salmonella outbreak; (4) Lack of quality control and standardization; (5) FDA's determination that kratom products are adulterated/misbranded; (6) Emerging evidence of seizure risk with concentrated 7-OH products.",
      "legalAlternatives": [
        "ashwagandha",
        "rhodiola-rosea",
        "l-theanine",
        "magnesium-glycinate"
      ],
      "metaTitle": "Kratom: Complete 2025 Guide | Legal Status, Withdrawal, & Alternatives",
      "metaDescription": "Comprehensive kratom guide: 2025 legal status by state (SB 154, SB 1868), withdrawal timeline, 10% taper protocol, safe alternatives. Updated Nov 2025.",
      "keywords": [
        "kratom",
        "kratom legal status 2025",
        "is kratom legal in my state",
        "kratom withdrawal",
        "kratom withdrawal timeline",
        "kratom taper",
        "kratom alternatives",
        "kratom ban",
        "louisiana kratom ban",
        "texas kratom law",
        "mitragyna speciosa",
        "kratom drug test",
        "kratom side effects"
      ],
      "isPillarPage": true,
      "pillarSections": [
        {
          "id": "what-is-kratom",
          "title": "What is Kratom?",
          "content": "<p><strong>Kratom (Mitragyna speciosa)</strong> is a tropical evergreen tree in the coffee family native to Southeast Asia, primarily Thailand, Malaysia, Indonesia, and Myanmar. The leaves contain over 40 alkaloids, with the two most pharmacologically significant being <strong>mitragynine</strong> (66% of alkaloid content) and <strong>7-hydroxymitragynine (7-OH)</strong>.</p><p>Kratom produces <strong>dose-dependent effects</strong>:</p><ul><li><strong>Low doses (1-5g):</strong> Stimulation, increased energy, alertness, and sociability—similar to coffee</li><li><strong>Moderate doses (5-10g):</strong> Analgesic effects, mild euphoria, reduced anxiety</li><li><strong>High doses (10-15g+):</strong> Sedation, opioid-like effects, pain relief, potential for nausea</li></ul><p>This biphasic action results from mitragynine's complex pharmacology: at low concentrations it activates adrenergic receptors (stimulation), while at higher concentrations mu-opioid receptor activity predominates (sedation/analgesia).</p><p><strong>Common Forms:</strong></p><ul><li><strong>Powder:</strong> Dried, crushed leaves—most common form</li><li><strong>Capsules:</strong> Measured powder doses for convenience</li><li><strong>Extracts:</strong> Concentrated products with elevated 7-OH levels—higher addiction and seizure risk</li><li><strong>Shots/Drinks:</strong> Liquid extracts often sold at gas stations</li></ul><p>While kratom has been used traditionally in Southeast Asia for centuries, its modern Western use as an opioid alternative has raised significant safety concerns, leading to FDA import alerts and state-level bans.</p>",
          "keywordTarget": "what is kratom"
        },
        {
          "id": "legal-status-2025",
          "title": "Kratom Legal Status 2025: State-by-State Map",
          "content": "<p>Kratom's legal status varies dramatically across the United States. As of November 2025, <strong>7 states have fully banned kratom</strong>, while <strong>15+ states have adopted the Kratom Consumer Protection Act (KCPA)</strong> with age restrictions and product standards.</p><h3>2025 Major Legislative Changes</h3><table><thead><tr><th>State</th><th>Bill</th><th>Effective Date</th><th>Key Provisions</th></tr></thead><tbody><tr><td><strong>Louisiana</strong></td><td>SB 154</td><td>Aug 1, 2025</td><td>Schedule I ban. $50,000 fine and 1-5 years for distribution. Possession: $1,000 or 6 months.</td></tr><tr><td><strong>Texas</strong></td><td>SB 1868</td><td>Sept 1, 2025</td><td>Strictest 7-OH limit in nation (0.1%). Age 21+. Synthetic alkaloids banned under Penalty Group 1.</td></tr><tr><td><strong>Georgia</strong></td><td>HB 181</td><td>Jan 1, 2025</td><td>Age raised to 21+. Strict labeling requirements. Vaping kratom prohibited.</td></tr><tr><td><strong>South Carolina</strong></td><td>SB 221</td><td>July 2025</td><td>KCPA framework with safety and labeling standards.</td></tr><tr><td><strong>Oklahoma</strong></td><td>SB 891</td><td>2025</td><td>Age 18+. Max 2% 7-OH. Lab testing required.</td></tr></tbody></table><h3>Fully Banned States (7)</h3><p><strong>Alabama, Arkansas, Indiana, Rhode Island, Vermont, Wisconsin, Louisiana</strong> (as of Aug 2025)</p><p>In these states, kratom is classified as a Schedule I controlled substance. Possession and sale carry criminal penalties.</p><h3>KCPA Regulation States (15+)</h3><p>States with Kratom Consumer Protection Acts regulate rather than ban: <strong>Arizona, Colorado, Florida, Georgia, Kentucky, Maryland, Nevada, Oklahoma, South Carolina, South Dakota, Tennessee, Texas, Utah, Virginia, West Virginia</strong></p><p>KCPA typically requires: age verification (18-21+), lab testing, labeling of alkaloid content, prohibition on synthetic alkaloids, and GMP manufacturing standards.</p><h3>Federal Status</h3><p>Kratom remains <strong>not scheduled</strong> at the federal level. However, the FDA maintains <strong>Import Alert 54-15</strong> allowing seizure of kratom products at ports. In July 2025, the FDA recommended scheduling <strong>7-hydroxymitragynine (7-OH)</strong> as a controlled substance—this targets concentrated extract products, not natural leaf kratom.</p>",
          "keywordTarget": "kratom legal status by state 2025"
        },
        {
          "id": "withdrawal-protocol",
          "title": "Kratom Withdrawal: Timeline & The 10% Taper Protocol",
          "content": "<p><strong>Never quit kratom cold turkey if you have significant dependence.</strong> Abrupt cessation causes uncomfortable withdrawal symptoms that peak around days 3-4.</p><h3>Withdrawal Timeline</h3><table><thead><tr><th>Phase</th><th>Duration</th><th>Symptoms</th></tr></thead><tbody><tr><td><strong>Early Withdrawal</strong></td><td>6-12 hours</td><td>Mild irritability, anxiety, muscle aches, sweating, runny nose</td></tr><tr><td><strong>Acute Withdrawal</strong></td><td>24-72 hours</td><td>Peak physical symptoms, intense muscle pain, severe GI distress, insomnia, RLS</td></tr><tr><td><strong>Subacute Phase</strong></td><td>Days 4-7</td><td>Gradual symptom reduction, lingering fatigue, reduced psychological intensity</td></tr><tr><td><strong>Late Withdrawal</strong></td><td>1-2 weeks</td><td>Most physical symptoms resolved, psychological symptoms may persist</td></tr><tr><td><strong>PAWS</strong></td><td>Weeks to months</td><td>Mood instability, anxiety, depression, cravings, cognitive effects</td></tr></tbody></table><h3>The 10% Weekly Reduction Protocol</h3><p>The evidence-based tapering approach involves <strong>reducing total daily dose by 10% every 7 days</strong>:</p><ol><li><strong>Establish baseline:</strong> Measure and record your exact daily intake using a digital scale (0.1g accuracy)</li><li><strong>Calculate reduction:</strong> Multiply daily dose by 0.9 for your new weekly target</li><li><strong>Divide doses:</strong> Split daily amount across your normal dosing schedule</li><li><strong>Hold if needed:</strong> If symptoms emerge, hold current dose until stable before continuing</li><li><strong>Slower at low doses:</strong> Below 5g/day, consider 5% reductions every 1-2 weeks</li></ol><p><strong>Example 20g/day taper:</strong> Week 1: 18g → Week 2: 16.2g → Week 3: 14.6g → Week 4: 13.1g... continuing until cessation</p><h3>Supportive Supplements</h3><ul><li><strong>Magnesium glycinate (400-800mg/day):</strong> Reduces RLS and muscle tension</li><li><strong>Vitamin C sodium ascorbate (megadose protocol):</strong> 5,000-25,000mg/day in divided doses during acute phase</li><li><strong>Black seed oil (1-2 tsp/day):</strong> May reduce cravings and anxiety</li><li><strong>L-theanine (200-400mg/day):</strong> For sleep and relaxation</li><li><strong>Ashwagandha (300-600mg/day):</strong> Cortisol modulation and stress reduction</li></ul>",
          "keywordTarget": "kratom withdrawal timeline"
        },
        {
          "id": "safety-side-effects",
          "title": "Safety Concerns & Side Effects",
          "content": "<h3>Documented Deaths</h3><p>The CDC documented <strong>91 overdose deaths involving kratom</strong> from 2016-2017. While most cases involved polysubstance use, kratom was identified as a contributing factor. A 2025 Neurology study identified <strong>113 kratom-induced seizures</strong> from Poison Control data (2011-2017), with risk elevated in concentrated 7-OH products.</p><h3>Serious Adverse Events</h3><ul><li><strong>Seizures:</strong> Increasing reports, especially with extract products. Standard urinalysis does not detect kratom; diagnosis often delayed 4+ days.</li><li><strong>Hepatotoxicity:</strong> Rare but documented liver injury in chronic users requiring hospitalization.</li><li><strong>Cardiac events:</strong> Case reports of tachycardia and arrhythmia at high doses.</li><li><strong>Respiratory depression:</strong> Possible when combined with other CNS depressants.</li></ul><h3>Common Side Effects</h3><table><thead><tr><th>System</th><th>Effects</th></tr></thead><tbody><tr><td><strong>Gastrointestinal</strong></td><td>Nausea, vomiting, constipation, appetite suppression</td></tr><tr><td><strong>Neurological</strong></td><td>Dizziness, tremor, seizures (high dose), cognitive impairment</td></tr><tr><td><strong>Psychological</strong></td><td>Anxiety, irritability, depression, insomnia</td></tr><tr><td><strong>Physical</strong></td><td>Dry mouth, sweating, weight loss, tolerance escalation</td></tr></tbody></table><h3>Drug Interactions</h3><p>Kratom inhibits CYP2D6 and CYP3A4 enzymes, potentially increasing levels of medications metabolized by these pathways. <strong>Dangerous combinations include:</strong></p><ul><li>Opioids (respiratory depression risk)</li><li>Benzodiazepines (enhanced sedation)</li><li>Alcohol (CNS depression)</li><li>MAO inhibitors (hypertensive crisis potential)</li><li>Antidepressants (serotonin syndrome risk with some SSRIs)</li></ul><h3>Contamination Issues</h3><p>The 2018 Salmonella outbreak infected 199 people across 41 states. Testing has also found kratom products contaminated with heavy metals, E. coli, and even synthetic opioids. The lack of FDA oversight means product quality varies dramatically.</p>",
          "keywordTarget": "kratom side effects dangers"
        }
      ],
      "faqs": [
        {
          "question": "Is kratom legal in my state in 2025?",
          "answer": "Kratom is fully banned in 7 states: Alabama, Arkansas, Indiana, Louisiana (as of Aug 1, 2025), Rhode Island, Vermont, and Wisconsin. It's legal with age restrictions (typically 21+) in 15+ KCPA states including Arizona, Florida, Georgia, and Texas. In remaining states, it's legal but unregulated. Check your specific state law before purchasing."
        },
        {
          "question": "How long does kratom withdrawal last?",
          "answer": "Acute kratom withdrawal symptoms typically last 4-10 days, with peak intensity around days 3-4. Physical symptoms (muscle aches, GI issues, RLS) usually resolve within 7-10 days. Psychological symptoms (anxiety, depression, cravings) may persist for weeks in Post-Acute Withdrawal Syndrome (PAWS). Duration depends on dose, frequency, and individual metabolism."
        },
        {
          "question": "Does kratom show up on a drug test?",
          "answer": "Standard 5-panel and 12-panel drug tests do NOT detect kratom. However, specialized tests for mitragynine exist and are increasingly used by probation offices, pain management clinics, and some employers. Kratom is detectable in urine for 5-7 days, blood for 24-48 hours, and hair for up to 90 days."
        },
        {
          "question": "Can you die from kratom withdrawal?",
          "answer": "There are no documented deaths solely from kratom withdrawal. Unlike alcohol or benzodiazepine withdrawal, kratom withdrawal does not typically cause seizures. However, severe dehydration from vomiting/diarrhea is a risk, and psychological distress including suicidal ideation has been reported. Medical supervision is recommended for heavy users."
        },
        {
          "question": "What is the safest way to quit kratom?",
          "answer": "The safest approach is a gradual taper: reduce your dose by 10% every 7 days until cessation. Use a digital scale for accuracy. Supportive supplements (magnesium, vitamin C, black seed oil) can help manage symptoms. For heavy users (>20g/day) or those with complications, medical supervision with potential buprenorphine bridge therapy may be appropriate."
        },
        {
          "question": "Is kratom an opioid?",
          "answer": "Kratom is classified as an 'atypical opioid.' Its primary alkaloids (mitragynine, 7-hydroxymitragynine) act on mu-opioid receptors like traditional opioids, but with additional activity at adrenergic, serotonergic, and other receptors. This creates both opioid-like effects (pain relief, sedation, withdrawal) and unique properties (stimulation at low doses). It produces physiological dependence and withdrawal similar to opioids."
        }
      ],
      "citations": [
        {
          "title": "Kratom Withdrawal: Discussions and conclusions of a scientific review",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10311168/",
          "source": "PMC/NIH",
          "year": "2023"
        },
        {
          "title": "FDA Information on Kratom",
          "url": "https://www.fda.gov/news-events/public-health-focus/fda-and-kratom",
          "source": "FDA",
          "year": "2025"
        },
        {
          "title": "Louisiana SB 154 - Kratom Scheduling",
          "url": "https://legis.la.gov/legis/BillInfo.aspx?s=25RS&b=SB154",
          "source": "Louisiana Legislature",
          "year": "2025"
        },
        {
          "title": "Texas SB 1868 - Kratom Consumer Protection",
          "url": "https://capitol.texas.gov/BillLookup/History.aspx?LegSess=89R&Bill=SB1868",
          "source": "Texas Legislature",
          "year": "2025"
        },
        {
          "title": "Kratom-Induced Seizures: Poison Control Data Analysis",
          "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11539871/",
          "source": "Neurology/PMC",
          "year": "2025"
        },
        {
          "title": "Long-Term Buprenorphine Treatment for Kratom Use Disorder",
          "url": "https://journals.sagepub.com/doi/10.1080/08897077.2021.2010250",
          "source": "Sage Journals",
          "year": "2022"
        }
      ],
      "relatedPages": [
        {
          "slug": "kratom-withdrawal-timeline",
          "title": "Kratom Withdrawal Timeline Day-by-Day",
          "type": "article",
          "relationship": "cluster"
        },
        {
          "slug": "kratom-taper-protocol",
          "title": "How to Taper Off Kratom Safely",
          "type": "article",
          "relationship": "cluster"
        },
        {
          "slug": "kratom-withdrawal-supplements",
          "title": "Supplements for Kratom Withdrawal",
          "type": "article",
          "relationship": "cluster"
        },
        {
          "slug": "kratom-legal-states-2025",
          "title": "Kratom Legal Status Map 2025",
          "type": "article",
          "relationship": "cluster"
        },
        {
          "slug": "kratom-drug-test",
          "title": "Does Kratom Show Up on Drug Tests?",
          "type": "article",
          "relationship": "cluster"
        },
        {
          "slug": "kratom-alternatives-pain",
          "title": "Natural Kratom Alternatives for Pain",
          "type": "article",
          "relationship": "cluster"
        },
        {
          "slug": "kratom-alternatives-energy",
          "title": "Kratom Alternatives for Energy",
          "type": "article",
          "relationship": "cluster"
        },
        {
          "slug": "ashwagandha",
          "title": "Ashwagandha",
          "type": "supplement",
          "relationship": "related"
        },
        {
          "slug": "rhodiola-rosea",
          "title": "Rhodiola Rosea",
          "type": "supplement",
          "relationship": "related"
        }
      ],
      "wikipediaSearchTerms": ["Kratom", "Mitragynine"],
      "createdAt": "2025-01-01T00:00:00Z",
      "updatedAt": "2025-11-29T00:00:00Z"
    },
    {
      "id": "banned-sarms",
      "slug": "sarms",
      "name": "SARMs (Selective Androgen Receptor Modulators)",
      "alternativeNames": [
        "Ostarine",
        "Ligandrol",
        "RAD-140",
        "Andarine",
        "MK-677"
      ],
      "category": "sarm",
      "legalStatus": "banned_usa",
      "legalStatusDetails": "Unapproved drugs - cannot be sold as dietary supplements. Felony charges for distribution.",
      "bannedBy": [
        "FDA",
        "WADA",
        "DOD"
      ],
      "stateRestrictions": {
        "US": "Federal - Unapproved drug",
        "Military": "ALL SARMs on DOD Prohibited List"
      },
      "healthRisks": [
        {
          "category": "Legal",
          "description": "Multiple felony convictions for SARM distribution (2024-2025). Criminal risk to suppliers AND users.",
          "severity": "high",
          "sources": [
            "DOJ Press Releases 2024"
          ]
        },
        {
          "category": "Hormonal",
          "description": "Testosterone suppression requiring Post-Cycle Therapy. Unknown long-term effects.",
          "severity": "moderate",
          "sources": [
            "Clinical case reports"
          ]
        }
      ],
      "sideEffects": [
        "Liver toxicity",
        "Cardiovascular events",
        "Testosterone suppression",
        "Cancer risk (animal studies)",
        "Mood changes"
      ],
      "contraindications": [
        "Hormone-sensitive cancers",
        "Liver disease",
        "Heart disease",
        "Women (virilization risk)"
      ],
      "overdoseRisk": "moderate",
      "addictionPotential": "moderate",
      "description": "SARMs are synthetic drugs that bind to androgen receptors, claiming to build muscle selectively. They are unapproved drugs with unknown long-term risks, often contaminated or mislabeled, and carry serious legal consequences.",
      "mechanism": "Bind to androgen receptors in muscle tissue, stimulating anabolic (muscle-building) effects. Claimed to be selective for muscle vs. prostate, but this selectivity is not proven in humans.",
      "history": "Developed by pharmaceutical companies in the 1990s for muscle wasting diseases. None have been FDA approved. Proliferated in the supplement industry as 'research chemicals' to skirt regulations.",
      "whyBanned": "Unapproved drugs with unknown long-term risks. FDA cannot ensure safety. Products often contaminated or mislabeled. Active criminal enforcement.",
      "legalAlternatives": [
        "creatine-monohydrate"
      ],
      "metaTitle": "SARMs - Why They're Illegal, Health Risks & Legal Alternatives",
      "metaDescription": "Learn why SARMs are illegal unapproved drugs, the criminal penalties, health risks, and discover safe legal alternatives for muscle building.",
      "keywords": [
        "sarms",
        "ostarine",
        "ligandrol",
        "rad-140",
        "sarms legal",
        "sarms ban",
        "sarms alternative"
      ],
      "createdAt": "2025-01-01T00:00:00Z",
      "updatedAt": "2025-01-27T00:00:00Z"
    },
    {
      "id": "banned-ephedrine",
      "slug": "ephedrine",
      "name": "Ephedrine",
      "alternativeNames": [
        "Ephedra",
        "Ma Huang",
        "Ephedra sinica alkaloid"
      ],
      "category": "stimulant",
      "legalStatus": "banned_usa",
      "legalStatusDetails": "Banned as dietary supplement ingredient since 2004. Landmark FDA ban case.",
      "bannedDate": "2004-04-12",
      "bannedBy": [
        "FDA",
        "WADA"
      ],
      "stateRestrictions": {
        "US": "Federal ban since 2004"
      },
      "healthRisks": [
        {
          "category": "Mortality",
          "description": "155 deaths attributed to ephedra products (FDA count, 1995-2004). 10,000+ adverse event reports.",
          "severity": "high",
          "sources": [
            "FDA Final Rule 2004"
          ]
        },
        {
          "category": "Cardiovascular",
          "description": "Heart attacks, strokes, arrhythmias, hypertensive crisis documented.",
          "severity": "high",
          "sources": [
            "RAND Corporation Analysis"
          ]
        }
      ],
      "sideEffects": [
        "Heart attack",
        "Stroke",
        "Arrhythmia",
        "Hypertensive crisis",
        "Seizures",
        "Myocardial infarction"
      ],
      "contraindications": [
        "Heart disease",
        "High blood pressure",
        "Diabetes",
        "Thyroid disease",
        "MAO inhibitor use"
      ],
      "overdoseRisk": "high",
      "addictionPotential": "moderate",
      "description": "Ephedrine is a sympathomimetic alkaloid that was widely used in weight loss and energy supplements until banned in 2004 after causing 155 deaths. This landmark case established modern FDA supplement oversight.",
      "mechanism": "Alpha and beta-adrenergic agonist. Stimulates heart rate, blood pressure, and thermogenesis. Similar to adrenaline in effects.",
      "history": "Used in traditional Chinese medicine for thousands of years. Became popular in US supplements in the 1990s. FDA banned after documenting 155 deaths. This case drove development of modern supplement regulations.",
      "whyBanned": "Unacceptable cardiovascular risk. Risk-benefit analysis showed benefits do not justify mortality risk. 155 deaths documented before ban.",
      "legalAlternatives": [
        "caffeine"
      ],
      "metaTitle": "Ephedrine (Ephedra) - Why It's Banned, 155 Deaths & Safe Alternatives",
      "metaDescription": "Learn why Ephedrine was banned after 155 deaths, its dangerous cardiovascular effects, and discover safe legal alternatives for weight loss and energy.",
      "keywords": [
        "ephedrine",
        "ephedra",
        "ma huang",
        "ephedra ban",
        "ephedrine deaths",
        "ephedrine alternative"
      ],
      "createdAt": "2025-01-01T00:00:00Z",
      "updatedAt": "2025-01-27T00:00:00Z"
    },
    {
      "id": "banned-clenbuterol",
      "slug": "clenbuterol",
      "name": "Clenbuterol",
      "alternativeNames": [
        "Clen",
        "Spiropent",
        "Beta-2 agonist"
      ],
      "category": "stimulant",
      "legalStatus": "banned_usa",
      "legalStatusDetails": "NOT approved for human use in USA. Approved only for veterinary use (horses).",
      "bannedBy": [
        "FDA",
        "WADA"
      ],
      "stateRestrictions": {
        "US": "Not approved for human use"
      },
      "healthRisks": [
        {
          "category": "Cardiovascular",
          "description": "Cardiac hypertrophy, arrhythmia, electrolyte imbalances. Limited human safety data.",
          "severity": "high",
          "sources": [
            "Clinical case reports"
          ]
        }
      ],
      "sideEffects": [
        "Cardiac hypertrophy",
        "Arrhythmia",
        "Tremors",
        "Muscle cramps",
        "Electrolyte imbalance",
        "Insomnia"
      ],
      "contraindications": [
        "Heart disease",
        "Arrhythmias",
        "Hypertension",
        "Hyperthyroidism"
      ],
      "overdoseRisk": "moderate",
      "addictionPotential": "low",
      "description": "Clenbuterol is a beta-2 agonist approved only for veterinary use in horses. It is used illegally in bodybuilding for fat loss and muscle preservation. Not studied extensively in humans.",
      "mechanism": "Beta-2 agonist - increases metabolism and fat mobilization. Also increases muscle protein synthesis. Causes cardiac hypertrophy with chronic use.",
      "history": "Developed as a bronchodilator. Approved for veterinary use in some countries. Used in bodybuilding communities since the 1980s. Food contamination incidents in Europe (2013).",
      "whyBanned": "Not approved for human use. Veterinary drug only. Cardiovascular risks exceed any potential benefits. No human safety data.",
      "legalAlternatives": [
        "caffeine"
      ],
      "metaTitle": "Clenbuterol - Why It's Illegal for Humans & Safe Alternatives",
      "metaDescription": "Learn why Clenbuterol is only approved for horses, the cardiovascular dangers, and discover safe legal alternatives for fat loss.",
      "keywords": [
        "clenbuterol",
        "clen",
        "clenbuterol legal",
        "clenbuterol ban",
        "clenbuterol alternative"
      ],
      "createdAt": "2025-01-01T00:00:00Z",
      "updatedAt": "2025-01-27T00:00:00Z"
    },
    {
      "id": "banned-gw501516",
      "slug": "cardarine",
      "name": "Cardarine (GW501516)",
      "alternativeNames": [
        "GW501516",
        "Endurobol",
        "GSX-R"
      ],
      "category": "other",
      "legalStatus": "banned_usa",
      "legalStatusDetails": "Never FDA approved. Development abandoned due to cancer risk at ALL tested doses.",
      "bannedBy": [
        "FDA (never approved)",
        "WADA"
      ],
      "healthRisks": [
        {
          "category": "Cancer",
          "description": "CANCER RISK - Caused multiple cancer types in animal studies at ALL tested doses. Development abandoned by GSK.",
          "severity": "high",
          "sources": [
            "GlaxoSmithKline internal studies"
          ]
        }
      ],
      "sideEffects": [
        "Multiple cancer types (animal studies)",
        "Liver toxicity",
        "Bladder cancer risk"
      ],
      "contraindications": [
        "Everyone - not safe for human use",
        "Any cancer history",
        "Liver disease"
      ],
      "overdoseRisk": "high",
      "addictionPotential": "low",
      "description": "Cardarine (GW501516) is a PPAR delta agonist that was abandoned during drug development after causing cancer in animal studies at ALL tested doses. One of the most dangerous compounds still sold online.",
      "mechanism": "Activates PPAR delta, increases fatty acid oxidation and endurance capacity. Also promotes cancer cell growth in multiple organ systems.",
      "history": "Developed by GlaxoSmithKline for metabolic diseases. Development abandoned after 2-year animal studies showed cancer at all doses. Still sold illegally online as 'research chemical'.",
      "whyBanned": "Cancer risk at ALL tested doses in animal models. Development abandoned by manufacturer due to unacceptable cancer risk. Never safe for human use.",
      "legalAlternatives": [
        "beta-alanine",
        "citrulline-malate"
      ],
      "metaTitle": "Cardarine (GW501516) - Cancer Risk Warning & Safe Alternatives",
      "metaDescription": "CRITICAL WARNING: Cardarine caused cancer at ALL doses in studies. Learn why GSK abandoned it and discover safe legal alternatives for endurance.",
      "keywords": [
        "cardarine",
        "gw501516",
        "cardarine cancer",
        "cardarine danger",
        "cardarine alternative",
        "endurobol"
      ],
      "createdAt": "2025-01-01T00:00:00Z",
      "updatedAt": "2025-01-27T00:00:00Z"
    },
    {
      "id": "banned-nandrolone",
      "slug": "nandrolone",
      "name": "Nandrolone (Deca-Durabolin)",
      "alternativeNames": [
        "Deca",
        "NPP",
        "Nandrolone Phenylpropionate",
        "19-nortestosterone"
      ],
      "category": "prohormone",
      "legalStatus": "controlled",
      "legalStatusDetails": "Schedule III controlled substance. Illegal without prescription. Felony possession.",
      "bannedBy": [
        "DEA",
        "WADA",
        "FDA (without Rx)"
      ],
      "stateRestrictions": {
        "US": "Schedule III Controlled Substance - Felony"
      },
      "healthRisks": [
        {
          "category": "Legal",
          "description": "Illegal possession is a felony. Most supply is from black market/counterfeits.",
          "severity": "high",
          "sources": [
            "DEA Scheduling"
          ]
        },
        {
          "category": "Hormonal",
          "description": "Testosterone suppression, testicular atrophy, requires PCT. Virilization in women.",
          "severity": "high",
          "sources": [
            "Clinical studies"
          ]
        }
      ],
      "sideEffects": [
        "Liver toxicity",
        "Cardiovascular effects",
        "Testicular atrophy",
        "Gynecomastia",
        "Virilization in women",
        "Mood effects"
      ],
      "contraindications": [
        "Prostate cancer",
        "Breast cancer",
        "Heart disease",
        "Liver disease",
        "Pregnancy"
      ],
      "overdoseRisk": "moderate",
      "addictionPotential": "high",
      "description": "Nandrolone is an anabolic androgenic steroid classified as a Schedule III controlled substance. Illegal possession is a felony. Most gym supply is from black market with unknown purity.",
      "mechanism": "Synthetic androgen. Binds to androgen receptors, stimulating protein synthesis and muscle growth. Suppresses natural testosterone production.",
      "history": "Developed in the 1950s for medical use. Classified as Schedule III controlled substance under the Anabolic Steroid Control Act. Still prescribed rarely for anemia and wasting diseases.",
      "whyBanned": "Controlled substance with abuse potential and significant health risks. Illegal without prescription. Black market products often contaminated.",
      "legalAlternatives": [
        "creatine-monohydrate"
      ],
      "metaTitle": "Nandrolone (Deca) - Schedule III Controlled Substance & Alternatives",
      "metaDescription": "Learn why Nandrolone is a Schedule III controlled substance (felony possession), health risks, and discover safe legal alternatives for muscle building.",
      "keywords": [
        "nandrolone",
        "deca durabolin",
        "deca",
        "npp",
        "anabolic steroids",
        "nandrolone alternative"
      ],
      "createdAt": "2025-01-01T00:00:00Z",
      "updatedAt": "2025-01-27T00:00:00Z"
    },
    {
      "id": "banned-dmha",
      "slug": "dmha",
      "name": "DMHA (Octodrine)",
      "alternativeNames": [
        "2-Aminoisoheptane",
        "Octodrine",
        "2-amino-6-methylheptane",
        "1,5-Dimethylhexylamine"
      ],
      "category": "stimulant",
      "legalStatus": "banned_usa",
      "legalStatusDetails": "FDA issued 12 warning letters in April 2019. Products containing DMHA are adulterated.",
      "bannedBy": [
        "FDA",
        "WADA"
      ],
      "stateRestrictions": {
        "US": "FDA Warning Letters",
        "Australia": "Banned"
      },
      "healthRisks": [
        {
          "category": "Cardiovascular",
          "description": "Supplements contained 72±7.5 mg per serving, more than twice historical pharmaceutical doses. Causes hypertension, tachycardia, hyperthermia.",
          "severity": "high",
          "sources": [
            "FDA Warning Letters 2019"
          ]
        }
      ],
      "sideEffects": [
        "Hypertension",
        "Tachycardia",
        "Hyperthermia",
        "Anxiety",
        "Jitters",
        "Insomnia"
      ],
      "contraindications": [
        "Heart conditions",
        "High blood pressure",
        "Anxiety disorders",
        "Stimulant sensitivity"
      ],
      "overdoseRisk": "high",
      "addictionPotential": "moderate",
      "description": "DMHA (2-aminoisoheptane) is a synthetic stimulant originally developed in the 1950s as an inhaled nasal decongestant—never approved for oral use. It emerged as a DMAA alternative in pre-workout supplements after the 2013 DMAA ban.",
      "mechanism": "Sympathomimetic amine that stimulates norepinephrine release, causing increased heart rate, blood pressure, and thermogenesis.",
      "history": "Originally patented in the 1950s as a nasal decongestant. Resurfaced in supplements around 2016 as 'DMAA alternative'. FDA cracked down in 2019 with 12 warning letters to companies including Hi-Tech Pharmaceuticals.",
      "whyBanned": "FDA determined DMHA is an unsafe food additive. Never tested for oral human use at supplement doses. Products are adulterated under DSHEA.",
      "legalAlternatives": [
        "caffeine",
        "citrulline-malate",
        "beta-alanine"
      ],
      "metaTitle": "DMHA (Octodrine) - FDA Banned Stimulant & Safe Alternatives",
      "metaDescription": "Learn why DMHA (2-aminoisoheptane, Octodrine) was banned by FDA in 2019, its dangerous cardiovascular effects, and discover safe legal pre-workout alternatives.",
      "keywords": [
        "dmha",
        "octodrine",
        "2-aminoisoheptane",
        "dmha pre workout",
        "dmha banned",
        "dmha alternative",
        "dmha side effects",
        "dmha dangers"
      ],
      "createdAt": "2025-01-27T00:00:00Z",
      "updatedAt": "2025-01-27T00:00:00Z"
    },
    {
      "id": "banned-bmpea",
      "slug": "bmpea",
      "name": "BMPEA",
      "alternativeNames": [
        "β-methylphenylethylamine",
        "Beta-methylphenethylamine",
        "2-Phenylpropan-1-amine"
      ],
      "category": "stimulant",
      "legalStatus": "banned_usa",
      "legalStatusDetails": "FDA issued 5 warning letters in April 2015. BMPEA is a synthetic adulterant, NOT naturally present in Acacia rigidula despite label claims.",
      "bannedBy": [
        "FDA"
      ],
      "stateRestrictions": {
        "US": "FDA Warning Letters 2015"
      },
      "healthRisks": [
        {
          "category": "Cardiovascular",
          "description": "Swedish case report documented cerebral hemorrhage in female athlete after consuming supplement with 290 mg BMPEA (unlabeled).",
          "severity": "high",
          "sources": [
            "FDA Research 2013",
            "Swedish Medical Case Report"
          ]
        }
      ],
      "sideEffects": [
        "Cerebral hemorrhage",
        "Hypertension",
        "Tachycardia",
        "Anxiety",
        "Palpitations",
        "Stroke"
      ],
      "contraindications": [
        "Heart conditions",
        "Stroke history",
        "High blood pressure",
        "Use of other stimulants"
      ],
      "overdoseRisk": "high",
      "addictionPotential": "moderate",
      "description": "BMPEA (β-methylphenylethylamine) is a positional isomer of amphetamine. FDA research in 2013 established it is NOT naturally present in Acacia rigidula—despite label claims, it is a synthetic adulterant with approximately 1/10th amphetamine potency.",
      "mechanism": "Substrate-type releaser at norepinephrine transporters. Structural isomer of amphetamine with similar but less potent stimulant effects on the central nervous system.",
      "history": "Marketed as 'natural' Acacia rigidula extract in numerous supplements. FDA scientifically proved it was a synthetic adulterant in 2013. Warning letters issued to 5 companies in April 2015.",
      "whyBanned": "Synthetic stimulant fraudulently labeled as natural plant extract. Never approved for human consumption. Amphetamine-like cardiovascular effects.",
      "legalAlternatives": [
        "caffeine",
        "l-tyrosine"
      ],
      "metaTitle": "BMPEA - Amphetamine Analog Banned by FDA & Safe Alternatives",
      "metaDescription": "BMPEA is an amphetamine isomer found as synthetic adulterant in 'Acacia rigidula' supplements. Learn why FDA banned it and find safe legal alternatives.",
      "keywords": [
        "bmpea",
        "beta-methylphenethylamine",
        "acacia rigidula",
        "bmpea supplement",
        "bmpea banned",
        "bmpea dangers",
        "bmpea amphetamine"
      ],
      "createdAt": "2025-01-27T00:00:00Z",
      "updatedAt": "2025-01-27T00:00:00Z"
    },
    {
      "id": "banned-tianeptine",
      "slug": "tianeptine",
      "name": "Tianeptine",
      "alternativeNames": [
        "Zaza",
        "Tianaa",
        "Neptune's Fix",
        "Gas Station Heroin",
        "Stablon",
        "Coaxil",
        "TD Red",
        "Zaza Red"
      ],
      "category": "other",
      "legalStatus": "restricted",
      "legalStatusDetails": "Scheduled in 12+ states including Alabama (Schedule I), Florida (Schedule I), Michigan (Schedule II), Ohio (Schedule I). FDA consumer warnings issued 2022-2025.",
      "bannedBy": [
        "FDA (warnings)",
        "Multiple states"
      ],
      "stateRestrictions": {
        "Alabama": "Schedule I",
        "Florida": "Schedule I",
        "Michigan": "Schedule II",
        "Ohio": "Schedule I",
        "Tennessee": "Schedule II",
        "Indiana": "Controlled",
        "Kentucky": "Controlled",
        "Georgia": "Controlled",
        "Mississippi": "Controlled"
      },
      "healthRisks": [
        {
          "category": "Opioid Toxicity",
          "description": "CDC documented poison center calls increasing from 11 total (2000-2013) to 391 in 2023. Effects mimic opioid toxicity and withdrawal. Users ingesting 1.3 to 250 times typical pharmaceutical doses.",
          "severity": "high",
          "sources": [
            "CDC MMWR August 2018",
            "CDC 2023 Report",
            "DEA Reports"
          ]
        }
      ],
      "sideEffects": [
        "Opioid-like euphoria",
        "Respiratory depression",
        "Severe withdrawal syndrome",
        "Seizures",
        "Coma",
        "Death",
        "Nausea",
        "Constipation"
      ],
      "contraindications": [
        "Opioid use disorder",
        "CNS depressant use",
        "Respiratory conditions",
        "Pregnancy",
        "Alcohol use"
      ],
      "overdoseRisk": "high",
      "addictionPotential": "high",
      "description": "Tianeptine is an atypical tricyclic antidepressant that acts as a mu-opioid receptor agonist. Known as 'gas station heroin' due to its availability at convenience stores and gas stations, and its severe opioid-like effects at high doses. Commonly sold as Zaza, Tianaa, Neptune's Fix, and TD Red.",
      "mechanism": "Mu-opioid receptor agonist causing euphoria and analgesia similar to traditional opioids. At high doses (commonly seen in abuse), produces full opioid toxicity including respiratory depression and severe physical dependence with life-threatening withdrawal.",
      "history": "Prescription drug in Europe, Asia, and Latin America since the 1980s for depression. Never FDA approved. Emerged in US as 'dietary supplement' around 2010. Multiple states scheduled after documented deaths and an addiction epidemic. Known as 'gas station heroin' crisis.",
      "whyBanned": "Opioid-like effects causing severe addiction, overdose, and death. Products sold at doses up to 250 times therapeutic levels. 'Gas station heroin' epidemic with opioid withdrawal syndrome.",
      "legalAlternatives": [
        "l-theanine",
        "ashwagandha",
        "rhodiola-rosea",
        "magnesium-glycinate"
      ],
      "metaTitle": "Tianeptine (Zaza, Gas Station Heroin) - Dangers, Deaths & Safer Alternatives",
      "metaDescription": "Tianeptine (Zaza, Tianaa, Neptune's Fix) is 'gas station heroin' causing severe opioid addiction and deaths. Learn the dangers, withdrawal symptoms, and find safe legal alternatives.",
      "keywords": [
        "tianeptine",
        "zaza",
        "tianaa",
        "neptunes fix",
        "gas station heroin",
        "tianeptine withdrawal",
        "tianeptine addiction",
        "tianeptine banned",
        "tianeptine deaths",
        "zaza red",
        "td red"
      ],
      "createdAt": "2025-01-27T00:00:00Z",
      "updatedAt": "2025-01-27T00:00:00Z"
    },
    {
      "id": "banned-adrafinil",
      "slug": "adrafinil",
      "name": "Adrafinil",
      "alternativeNames": [
        "CRL-40028",
        "Olmifon"
      ],
      "category": "nootropic",
      "legalStatus": "banned_usa",
      "legalStatusDetails": "FDA classified as unapproved new drug. Criminal prosecutions with prison sentences for sellers. In 2023, Nootropics Depot CEO was sentenced to prison and ordered to forfeit $2.4 million.",
      "bannedBy": [
        "FDA",
        "WADA"
      ],
      "stateRestrictions": {
        "US": "Unapproved Drug - Criminal Prosecution Active"
      },
      "healthRisks": [
        {
          "category": "Hepatotoxicity",
          "description": "Liver enzyme elevations with prolonged use. The prodrug form was voluntarily discontinued in France in 2011 due to 'unfavorable risk-benefit ratio' from liver concerns.",
          "severity": "moderate",
          "sources": [
            "French Health Authority 2011",
            "Clinical Reports"
          ]
        },
        {
          "category": "Legal",
          "description": "2023: Nootropics Depot CEO sentenced to prison, $2.4 million forfeiture for selling adrafinil, tianeptine, and phenibut.",
          "severity": "high",
          "sources": [
            "DOJ Press Release 2023"
          ]
        }
      ],
      "sideEffects": [
        "Liver toxicity",
        "Elevated liver enzymes",
        "Insomnia",
        "Anxiety",
        "Headache",
        "Nausea",
        "Skin reactions"
      ],
      "contraindications": [
        "Liver disease",
        "Heart conditions",
        "Seizure disorders",
        "Pregnancy",
        "Other hepatotoxic drugs"
      ],
      "overdoseRisk": "moderate",
      "addictionPotential": "low",
      "description": "Adrafinil is a prodrug of modafinil, a DEA Schedule IV controlled substance. It requires hepatic metabolism to produce the active drug, placing significant strain on the liver. Selling adrafinil has resulted in criminal prosecution and prison time for supplement sellers.",
      "mechanism": "Metabolized by the liver into modafinil (Schedule IV). Increases dopamine and norepinephrine neurotransmission, promoting wakefulness. Hepatotoxic due to extensive first-pass metabolism required for activation.",
      "history": "Developed in France in the 1970s by Lafon Laboratories for narcolepsy treatment. Voluntarily discontinued in France in 2011 due to liver risks and availability of modafinil. US supplement sellers prosecuted criminally in 2023.",
      "whyBanned": "Prodrug of DEA Schedule IV controlled substance (modafinil). Classified as unapproved new drug by FDA. Hepatotoxic. Active criminal enforcement with prison sentences.",
      "legalAlternatives": [
        "caffeine",
        "l-theanine",
        "alpha-gpc",
        "lions-mane"
      ],
      "metaTitle": "Adrafinil - Modafinil Prodrug, Liver Damage, Prison Sentences & Safe Alternatives",
      "metaDescription": "Adrafinil is a prodrug of modafinil that causes liver damage. Learn why sellers are going to prison and find safe legal nootropic alternatives for focus and wakefulness.",
      "keywords": [
        "adrafinil",
        "olmifon",
        "adrafinil liver",
        "adrafinil modafinil",
        "adrafinil legal",
        "adrafinil banned",
        "adrafinil alternative",
        "adrafinil side effects",
        "adrafinil hepatotoxicity"
      ],
      "createdAt": "2025-01-27T00:00:00Z",
      "updatedAt": "2025-01-27T00:00:00Z"
    },
    {
      "id": "banned-phenylpiracetam",
      "slug": "phenylpiracetam",
      "name": "Phenylpiracetam",
      "alternativeNames": [
        "Carphedon",
        "Phenotropil",
        "4-Phenylpiracetam",
        "Fonturacetam"
      ],
      "category": "nootropic",
      "legalStatus": "banned_usa",
      "legalStatusDetails": "FDA classifies as unapproved new drug. WADA prohibited since 1998—the ONLY racetam on WADA's banned list. Named in 2022-2023 criminal enforcement actions.",
      "bannedBy": [
        "FDA",
        "WADA"
      ],
      "stateRestrictions": {
        "US": "Unapproved Drug - Criminal Enforcement",
        "Russia": "Prescription Only (Phenotropil)"
      },
      "healthRisks": [
        {
          "category": "Sports/Legal",
          "description": "Multiple doping cases including Russian Olympic biathlete Olga Pyleva (2006 silver medal stripped). Named in 2022-2023 US criminal enforcement actions against supplement sellers.",
          "severity": "high",
          "sources": [
            "WADA Doping Cases",
            "DOJ Enforcement 2023"
          ]
        }
      ],
      "sideEffects": [
        "Insomnia",
        "Irritability",
        "Headache",
        "Overstimulation",
        "Anxiety",
        "Increased blood pressure"
      ],
      "contraindications": [
        "Competitive athletes (career-ending)",
        "Anxiety disorders",
        "Insomnia",
        "Hypertension"
      ],
      "overdoseRisk": "low",
      "addictionPotential": "low",
      "description": "Phenylpiracetam (Carphedon) is the ONLY racetam on WADA's prohibited list, banned in-competition since 1998. It's a prescription drug in Russia for cerebrovascular deficiency and depression. FDA classifies it as an unapproved drug in the US, and it has been named in criminal enforcement actions.",
      "mechanism": "Racetam nootropic with an added phenyl group that significantly increases potency and adds stimulant-like effects. Enhances dopamine and norepinephrine activity beyond other racetams.",
      "history": "Developed in Russia in 1983 for Soviet cosmonauts to combat stress and cold tolerance. Approved in Russia as prescription drug Phenotropil in 2003. Multiple Olympic doping scandals. US criminal enforcement 2022-2023.",
      "whyBanned": "Unapproved drug with significant stimulant properties. The ONLY WADA-banned racetam due to performance enhancing effects. Career-ending for competitive athletes.",
      "legalAlternatives": [
        "caffeine",
        "alpha-gpc",
        "lions-mane",
        "bacopa-monnieri"
      ],
      "metaTitle": "Phenylpiracetam (Carphedon) - WADA Banned, Only Banned Racetam & Legal Alternatives",
      "metaDescription": "Phenylpiracetam is the ONLY racetam banned by WADA since 1998. Learn why athletes lose Olympic medals and careers, and find safe legal nootropic alternatives.",
      "keywords": [
        "phenylpiracetam",
        "carphedon",
        "phenotropil",
        "phenylpiracetam banned",
        "phenylpiracetam wada",
        "phenylpiracetam legal",
        "phenylpiracetam alternative",
        "phenylpiracetam doping"
      ],
      "createdAt": "2025-01-27T00:00:00Z",
      "updatedAt": "2025-01-27T00:00:00Z"
    },
    {
      "id": "banned-ostarine",
      "slug": "ostarine",
      "name": "Ostarine (MK-2866)",
      "alternativeNames": [
        "MK-2866",
        "Enobosarm",
        "GTx-024",
        "S-22"
      ],
      "category": "sarm",
      "legalStatus": "banned_usa",
      "legalStatusDetails": "Unapproved drug—cannot legally be sold as supplement or for human consumption. 20+ drug-induced liver injury cases documented in medical literature since 2020. Active criminal enforcement.",
      "bannedBy": [
        "FDA",
        "WADA",
        "DEA (enforcement)"
      ],
      "stateRestrictions": {
        "US": "Unapproved Drug - Criminal Enforcement Active"
      },
      "healthRisks": [
        {
          "category": "Hepatotoxicity",
          "description": "Over 20 drug-induced liver injury (DILI) cases documented in NIH PubMed medical literature since 2020. Cholestatic liver injury pattern.",
          "severity": "high",
          "sources": [
            "NIH PubMed Case Reports",
            "Hepatology Journals"
          ]
        },
        {
          "category": "Hormonal",
          "description": "Significant testosterone suppression requiring Post-Cycle Therapy. Development discontinued after failing to improve muscle strength in cancer patient trials.",
          "severity": "moderate",
          "sources": [
            "GTx Clinical Trials"
          ]
        }
      ],
      "sideEffects": [
        "Liver injury",
        "Testosterone suppression",
        "Acne",
        "Hair loss",
        "Mood changes",
        "Gynecomastia",
        "Cholestatic jaundice"
      ],
      "contraindications": [
        "Liver disease",
        "Hormone-sensitive conditions",
        "Women (virilization risk)",
        "Competitive athletes"
      ],
      "overdoseRisk": "moderate",
      "addictionPotential": "moderate",
      "description": "Ostarine (MK-2866/Enobosarm) is the most commonly detected SARM in both doping tests and supplement adulteration testing. Development by GTx was discontinued after failing Phase 3 clinical trials to improve muscle strength in cancer patients. Over 20 documented liver injury cases.",
      "mechanism": "Selective Androgen Receptor Modulator that binds to androgen receptors primarily in muscle and bone tissue. Despite claimed selectivity, causes significant testosterone suppression requiring PCT.",
      "history": "Developed by GTx Inc. for cancer-related muscle wasting. Failed Phase 3 clinical trials. Most detected SARM globally with over 230 positive doping tests since 2012. Frequently found as undeclared adulterant in supplements.",
      "whyBanned": "Unapproved drug causing documented liver injury cases. Development abandoned after failing efficacy trials. Most common SARM in doping violations and supplement adulteration.",
      "legalAlternatives": [
        "creatine-monohydrate"
      ],
      "metaTitle": "Ostarine (MK-2866) - Liver Injury Risk, Failed Trials & Legal Alternatives",
      "metaDescription": "Ostarine (MK-2866) causes liver damage with 20+ documented cases. Learn why this SARM failed clinical trials and find safe legal muscle-building alternatives.",
      "keywords": [
        "ostarine",
        "mk-2866",
        "enobosarm",
        "ostarine side effects",
        "ostarine liver",
        "ostarine legal",
        "ostarine alternative",
        "ostarine banned",
        "ostarine liver damage"
      ],
      "createdAt": "2025-01-27T00:00:00Z",
      "updatedAt": "2025-01-27T00:00:00Z"
    },
    {
      "id": "banned-andarine",
      "slug": "andarine",
      "name": "Andarine (S-4)",
      "alternativeNames": [
        "S-4",
        "GTx-007",
        "Acetamidoxolutamide"
      ],
      "category": "sarm",
      "legalStatus": "banned_usa",
      "legalStatusDetails": "Unapproved drug. Development discontinued in favor of ostarine due to unique and concerning vision side effects.",
      "bannedBy": [
        "FDA",
        "WADA"
      ],
      "stateRestrictions": {
        "US": "Unapproved Drug"
      },
      "healthRisks": [
        {
          "category": "Vision",
          "description": "Unique and concerning side effect: visual disturbances including yellow-tinted vision (everything appears yellow) and significant difficulty adjusting to darkness/night blindness.",
          "severity": "moderate",
          "sources": [
            "User Reports",
            "Clinical Observations",
            "Pharmacology Studies"
          ]
        }
      ],
      "sideEffects": [
        "Yellow vision tint",
        "Night vision problems/blindness",
        "Difficulty adjusting to light changes",
        "Testosterone suppression",
        "Liver stress",
        "Hair loss"
      ],
      "contraindications": [
        "Vision problems",
        "Driving at night",
        "Liver disease",
        "Hormone-sensitive conditions",
        "Pilots/drivers"
      ],
      "overdoseRisk": "moderate",
      "addictionPotential": "moderate",
      "description": "Andarine (S-4) is a SARM with a unique and particularly concerning side effect: vision disturbances including yellow-tinted vision and significant difficulty adjusting to darkness. Development was discontinued in favor of ostarine due to these vision problems.",
      "mechanism": "Binds to androgen receptors in muscle tissue but ALSO binds to receptors in the eye's retina, causing the characteristic yellow vision and night blindness. Less selective than originally claimed.",
      "history": "Early SARM developed by GTx Inc. Discontinued during development due to the unexpected and concerning vision side effects. Development efforts shifted to ostarine instead.",
      "whyBanned": "Unapproved drug with unique vision impairment side effects that could endanger users (driving, operating machinery). Never completed clinical development due to safety concerns.",
      "legalAlternatives": [
        "creatine-monohydrate"
      ],
      "metaTitle": "Andarine (S-4) - Yellow Vision, Night Blindness & Safer Alternatives",
      "metaDescription": "Andarine (S-4) causes yellow-tinted vision and night blindness. Learn why this SARM was abandoned and find safe legal muscle-building alternatives.",
      "keywords": [
        "andarine",
        "s-4",
        "andarine vision",
        "andarine side effects",
        "andarine yellow vision",
        "andarine night blindness",
        "andarine legal",
        "andarine alternative"
      ],
      "createdAt": "2025-01-27T00:00:00Z",
      "updatedAt": "2025-01-27T00:00:00Z"
    },
    {
      "id": "banned-yohimbine",
      "slug": "yohimbine",
      "name": "Yohimbine/Yohimbe",
      "alternativeNames": [
        "Yohimbe bark",
        "Pausinystalia yohimbe",
        "Yohimbine HCl",
        "Quebrachine"
      ],
      "category": "other",
      "legalStatus": "restricted",
      "legalStatusDetails": "Yohimbine HCl is an FDA-approved PRESCRIPTION drug. Yohimbe bark extract sold as supplement but with 5.81x higher serious outcome rate than average poisonings.",
      "bannedBy": [
        "FDA (prescription requirement for pure form)"
      ],
      "stateRestrictions": {
        "US": "Yohimbine HCl = Prescription Only; Yohimbe bark = High-risk supplement"
      },
      "healthRisks": [
        {
          "category": "Cardiovascular",
          "description": "California Poison Control System study (2000-2006): 238 yohimbine cases with 5.81x higher odds of serious outcomes than average poison exposures. Documented cardiac arrhythmias, myocardial infarction, seizures, and acute renal failure.",
          "severity": "high",
          "sources": [
            "California Poison Control System 2000-2006",
            "Clinical Case Reports"
          ]
        }
      ],
      "sideEffects": [
        "Cardiac arrhythmias",
        "Hypertension",
        "Myocardial infarction",
        "Anxiety",
        "Panic attacks",
        "Seizures",
        "Acute renal failure",
        "Tremor"
      ],
      "contraindications": [
        "Heart disease",
        "Anxiety disorders",
        "Hypertension",
        "Kidney disease",
        "MAO inhibitor use",
        "SSRI use"
      ],
      "overdoseRisk": "high",
      "addictionPotential": "low",
      "description": "Yohimbine is an α2-adrenergic receptor antagonist from yohimbe bark. The pure compound (yohimbine HCl) is an FDA-approved prescription drug for erectile dysfunction. Bark extracts sold as supplements have highly variable yohimbine content (up to 154% variation) with inadequate safety labeling and 5.81x higher serious outcome rate.",
      "mechanism": "Blocks α2-adrenergic receptors, causing increased norepinephrine release throughout the body. Results in elevated blood pressure, heart rate, and anxiety. Also affects fat mobilization.",
      "history": "Traditional use in West Africa as aphrodisiac. Yohimbine HCl approved as prescription drug for ED. Bark supplements are poorly regulated with a 2015 analysis of 49 supplements showing highly variable and often undisclosed yohimbine content.",
      "whyBanned": "Pure yohimbine requires prescription. Bark supplements have dangerous content variability and 5.81x higher odds of serious poisoning outcomes including cardiac events and seizures.",
      "legalAlternatives": [
        "caffeine",
        "l-carnitine"
      ],
      "metaTitle": "Yohimbine/Yohimbe - 5.81x More Dangerous, Heart Risks & Safer Alternatives",
      "metaDescription": "Yohimbine causes cardiac arrhythmias with 5.81x more serious poisonings than average. Learn the risks of yohimbe supplements and find safe legal fat loss alternatives.",
      "keywords": [
        "yohimbine",
        "yohimbe",
        "yohimbine side effects",
        "yohimbe dangers",
        "yohimbine heart",
        "yohimbe legal",
        "yohimbine alternative",
        "yohimbe bark"
      ],
      "createdAt": "2025-01-27T00:00:00Z",
      "updatedAt": "2025-01-27T00:00:00Z"
    },
    {
      "id": "banned-higenamine",
      "slug": "higenamine",
      "name": "Higenamine",
      "alternativeNames": [
        "Norcoclaurine",
        "Demethylcoclaurine",
        "1-[(4-hydroxyphenyl)methyl]-1,2,3,4-tetrahydroisoquinoline-6,7-diol"
      ],
      "category": "stimulant",
      "legalStatus": "restricted",
      "legalStatusDetails": "FDA warning letters May 2022—determined to be a New Dietary Ingredient requiring premarket notification (none submitted). WADA prohibited at ALL times since 2017.",
      "bannedBy": [
        "FDA (NDI requirement)",
        "WADA"
      ],
      "stateRestrictions": {
        "US": "NDI Required - Products Adulterated",
        "Sports": "WADA Prohibited - All Competition Times"
      },
      "healthRisks": [
        {
          "category": "Sports/Career",
          "description": "WADA prohibited since 2017 under S3 Beta-2 Agonists. Reporting threshold: 10 ng/mL in urine. Caused UEFA footballer Mamadou Sakho's suspension in 2016. Multiple athlete career-ending suspensions.",
          "severity": "high",
          "sources": [
            "WADA Prohibited List",
            "Doping Cases"
          ]
        }
      ],
      "sideEffects": [
        "Tachycardia",
        "Palpitations",
        "Tremor",
        "Anxiety",
        "Headache",
        "Arrhythmias"
      ],
      "contraindications": [
        "Competitive athletes (career-ending)",
        "Heart conditions",
        "Arrhythmias",
        "Asthma medication use (β2 agonists)"
      ],
      "overdoseRisk": "moderate",
      "addictionPotential": "low",
      "description": "Higenamine is a β2-adrenergic agonist found naturally in lotus seeds, Nandina domestica, aconite root, and beetroot. FDA determined it requires New Dietary Ingredient notification (none submitted). WADA banned since 2017—has ended athletic careers including UEFA footballer Mamadou Sakho.",
      "mechanism": "Activates β2-adrenergic receptors causing bronchodilation, increased heart rate, and thermogenesis. Effects similar to ephedrine and other banned β2 agonists.",
      "history": "Traditional use in Chinese medicine (lotus seeds). Emerged in pre-workout supplements around 2015. WADA added to prohibited list effective January 2017. FDA issued warning letters May 2022 for missing NDI notifications.",
      "whyBanned": "New Dietary Ingredient without required FDA premarket notification. WADA prohibited as β2-agonist at all times. Career-ending for competitive athletes in any sport.",
      "legalAlternatives": [
        "caffeine",
        "citrulline-malate",
        "beta-alanine"
      ],
      "metaTitle": "Higenamine - WADA Banned, Career-Ending for Athletes & Safe Alternatives",
      "metaDescription": "Higenamine is banned by WADA and flagged by FDA. Learn why athletes lose careers over this ingredient and find safe legal pre-workout alternatives.",
      "keywords": [
        "higenamine",
        "higenamine banned",
        "higenamine wada",
        "higenamine fda",
        "higenamine legal",
        "higenamine supplement",
        "higenamine alternative",
        "higenamine doping"
      ],
      "createdAt": "2025-01-27T00:00:00Z",
      "updatedAt": "2025-01-27T00:00:00Z"
    },
    {
      "id": "banned-vinpocetine",
      "slug": "vinpocetine",
      "name": "Vinpocetine",
      "alternativeNames": [
        "Ethyl apovincaminate",
        "Cavinton",
        "Intelectol"
      ],
      "category": "nootropic",
      "legalStatus": "restricted",
      "legalStatusDetails": "FDA June 2019 critical pregnancy warning—NIH found clear evidence it causes miscarriages and fetal harm. FDA tentatively ruled vinpocetine ineligible for dietary supplement status.",
      "bannedBy": [
        "FDA (pregnancy warning, tentative ineligibility ruling)"
      ],
      "stateRestrictions": {
        "US": "FDA Pregnancy Warning - Tentatively Ineligible for Supplements"
      },
      "healthRisks": [
        {
          "category": "Reproductive",
          "description": "NIH National Toxicology Program found clear evidence vinpocetine triggers miscarriages and causes fetal harm in animal studies at blood levels similar to humans after taking a SINGLE dose.",
          "severity": "high",
          "sources": [
            "NIH National Toxicology Program Study",
            "FDA Safety Alert June 2019"
          ]
        }
      ],
      "sideEffects": [
        "Miscarriage",
        "Fetal harm/developmental toxicity",
        "Headache",
        "Dizziness",
        "Nausea",
        "Sleep disturbances",
        "Facial flushing"
      ],
      "contraindications": [
        "Pregnancy",
        "Women of childbearing age",
        "Women trying to conceive",
        "Bleeding disorders",
        "Surgery patients"
      ],
      "overdoseRisk": "low",
      "addictionPotential": "low",
      "description": "Vinpocetine is a synthetic derivative of vincamine used for cognitive enhancement. FDA issued a CRITICAL pregnancy warning in June 2019: 'Women who are pregnant or who could become pregnant should not take vinpocetine' due to NIH evidence of miscarriage and fetal harm at normal supplement doses.",
      "mechanism": "Phosphodiesterase inhibitor that increases cerebral blood flow. Also affects fetal development, causing pregnancy loss and developmental abnormalities in offspring.",
      "history": "Synthesized from periwinkle plant (vinca) alkaloids. Prescription drug in Europe and Japan for cerebrovascular disorders. FDA issued critical pregnancy warning June 2019 after NIH National Toxicology Program findings. Tentatively ruled ineligible for supplement status.",
      "whyBanned": "Causes miscarriages and fetal harm at NORMAL supplement doses—effects seen at blood levels achieved after a single dose. FDA explicitly warns ALL women of childbearing age to avoid. Tentatively ruled ineligible for dietary supplements.",
      "legalAlternatives": [
        "alpha-gpc",
        "lions-mane",
        "bacopa-monnieri"
      ],
      "metaTitle": "Vinpocetine - CAUSES MISCARRIAGE, FDA Pregnancy Warning & Safe Alternatives",
      "metaDescription": "CRITICAL: FDA warns vinpocetine causes miscarriages and fetal harm. Women of childbearing age should NOT take it. Find safe legal cognitive enhancement alternatives.",
      "keywords": [
        "vinpocetine",
        "vinpocetine pregnancy",
        "vinpocetine miscarriage",
        "vinpocetine fda warning",
        "vinpocetine safe",
        "vinpocetine alternative",
        "vinpocetine dangers"
      ],
      "createdAt": "2025-01-27T00:00:00Z",
      "updatedAt": "2025-01-27T00:00:00Z"
    },
    {
      "id": "banned-picamilon",
      "slug": "picamilon",
      "name": "Picamilon",
      "alternativeNames": [
        "Nicotinoyl-GABA",
        "Pikamilon",
        "N-nicotinoyl-GABA",
        "Nicotinoyl-gamma-aminobutyric acid"
      ],
      "category": "nootropic",
      "legalStatus": "banned_usa",
      "legalStatusDetails": "FDA issued 5 warning letters in November 2015 determining picamilon does NOT meet the dietary ingredient definition—it is a 'unique chemical entity synthesized from dietary ingredients' that crosses the blood-brain barrier.",
      "bannedBy": [
        "FDA"
      ],
      "stateRestrictions": {
        "US": "Not a Dietary Ingredient - Products Adulterated",
        "Russia": "Prescription Drug"
      },
      "healthRisks": [
        {
          "category": "Dosage Variability",
          "description": "Testing found supplements containing 2.7 to 721.5 mg per daily serving—compared to Russian prescription doses of only 50-100 mg. Extreme and dangerous variability.",
          "severity": "moderate",
          "sources": [
            "FDA Product Testing 2015",
            "Analytical Chemistry Studies"
          ]
        }
      ],
      "sideEffects": [
        "Hypotension",
        "Dizziness",
        "Headache",
        "Nausea",
        "Flushing",
        "Allergic reactions"
      ],
      "contraindications": [
        "Low blood pressure",
        "Kidney disease",
        "Pregnancy",
        "Chronic hypotension"
      ],
      "overdoseRisk": "low",
      "addictionPotential": "low",
      "description": "Picamilon is a synthetic niacin-GABA prodrug that crosses the blood-brain barrier intact and accumulates in the brain as a separate chemical entity. FDA ruled it is NOT a dietary ingredient because it's a 'unique chemical entity synthesized from dietary ingredients'—not the same as taking GABA and niacin separately.",
      "mechanism": "Crosses the blood-brain barrier intact, then is cleaved by brain enzymes into niacin and GABA. This provides GABA effects in the brain that are NOT achievable from oral GABA supplements (which don't cross the BBB).",
      "history": "Developed in the Soviet Union in 1969. Prescription drug in Russia for anxiety, cerebrovascular disease, and depression. FDA banned as a supplement ingredient in November 2015. Despite ruling, continued appearing in supplements through 2020.",
      "whyBanned": "Not a dietary ingredient—synthetic prodrug designed to cross the BBB. Extreme dosage variability in supplements (2.7-721.5 mg vs 50-100 mg prescription). Chemical manipulation to bypass normal GABA limitations.",
      "legalAlternatives": [
        "l-theanine",
        "magnesium-glycinate",
        "ashwagandha"
      ],
      "metaTitle": "Picamilon - FDA Banned Synthetic GABA Prodrug & Legal Alternatives",
      "metaDescription": "Picamilon is a synthetic GABA prodrug banned by FDA in 2015—not a legal supplement. Learn why it's not the same as GABA and find safe legal relaxation alternatives.",
      "keywords": [
        "picamilon",
        "pikamilon",
        "picamilon banned",
        "picamilon fda",
        "picamilon legal",
        "picamilon alternative",
        "picamilon gaba",
        "nicotinoyl gaba"
      ],
      "createdAt": "2025-01-27T00:00:00Z",
      "updatedAt": "2025-01-27T00:00:00Z"
    },
    {
      "id": "banned-amp-citrate",
      "slug": "amp-citrate",
      "name": "AMP Citrate (DMBA)",
      "alternativeNames": [
        "DMBA",
        "4-amino-2-methylpentane citrate",
        "1,3-Dimethylbutylamine",
        "4-AMP"
      ],
      "category": "stimulant",
      "legalStatus": "banned_usa",
      "legalStatusDetails": "FDA issued 14 warning letters in April 2015. Never tested in human clinical trials—health effects entirely unknown.",
      "bannedBy": [
        "FDA"
      ],
      "stateRestrictions": {
        "US": "FDA Warning Letters 2015"
      },
      "healthRisks": [
        {
          "category": "Unknown",
          "description": "NEVER evaluated in human clinical trials. Supplements contained 13-120 mg per serving—health effects are entirely unknown. This is a completely untested synthetic stimulant.",
          "severity": "high",
          "sources": [
            "FDA Warning Letters 2015"
          ]
        }
      ],
      "sideEffects": [
        "Unknown - never clinically tested",
        "Presumed cardiovascular effects",
        "Hypertension",
        "Tachycardia",
        "Anxiety"
      ],
      "contraindications": [
        "Heart conditions",
        "High blood pressure",
        "Unknown drug interactions"
      ],
      "overdoseRisk": "high",
      "addictionPotential": "moderate",
      "description": "AMP Citrate (DMBA/1,3-Dimethylbutylamine) is a synthetic stimulant that was NEVER tested in human clinical trials. FDA issued 14 warning letters in April 2015 to companies including VPX Sports. The health effects are entirely unknown—this is essentially an untested experimental drug.",
      "mechanism": "Presumed sympathomimetic amine similar to DMAA, but actual mechanism unknown due to lack of any clinical research.",
      "history": "Emerged as DMAA alternative around 2013-2014. FDA cracked down in April 2015 with 14 warning letters. Never underwent any human safety testing.",
      "whyBanned": "Untested synthetic stimulant with completely unknown safety profile. Zero human clinical data. Products are adulterated under DSHEA.",
      "legalAlternatives": [
        "caffeine",
        "citrulline-malate"
      ],
      "metaTitle": "AMP Citrate (DMBA) - Untested Stimulant Banned by FDA & Alternatives",
      "metaDescription": "AMP Citrate (DMBA) was NEVER tested on humans. Learn why FDA banned this dangerous untested stimulant and find safe legal pre-workout alternatives.",
      "keywords": [
        "amp citrate",
        "dmba",
        "dmba pre workout",
        "amp citrate banned",
        "1,3-dimethylbutylamine",
        "amp citrate side effects"
      ],
      "createdAt": "2025-01-27T00:00:00Z",
      "updatedAt": "2025-01-27T00:00:00Z"
    },
    {
      "id": "banned-methylsynephrine",
      "slug": "methylsynephrine",
      "name": "Methylsynephrine (Oxilofrine)",
      "alternativeNames": [
        "Oxilofrine",
        "Oxyephrine",
        "4-HMP",
        "p-Hydroxyephedrine"
      ],
      "category": "stimulant",
      "legalStatus": "banned_usa",
      "legalStatusDetails": "FDA issued 7 warning letters in March 2016. WADA prohibited. Caused doping suspensions for Olympic sprinters.",
      "bannedBy": [
        "FDA",
        "WADA"
      ],
      "stateRestrictions": {
        "US": "FDA Warning Letters 2016",
        "Sports": "WADA Prohibited"
      },
      "healthRisks": [
        {
          "category": "Cardiovascular",
          "description": "FDA received 47 adverse event reports including vomiting, chest pain, and cardiac arrest. Supplements contained up to 250 mg/day vs pharmaceutical doses of 16-40 mg.",
          "severity": "high",
          "sources": [
            "FDA Adverse Events",
            "FDA Warning Letters 2016"
          ]
        }
      ],
      "sideEffects": [
        "Cardiac arrest",
        "Chest pain",
        "Vomiting",
        "Hypertension",
        "Tachycardia",
        "Palpitations"
      ],
      "contraindications": [
        "Heart conditions",
        "High blood pressure",
        "Competitive athletes",
        "Arrhythmias"
      ],
      "overdoseRisk": "high",
      "addictionPotential": "moderate",
      "description": "Methylsynephrine (Oxilofrine) is a stimulant banned by both FDA and WADA. FDA received 47 adverse event reports including cardiac arrest. Supplements contained doses up to 6x higher than pharmaceutical levels. Caused doping suspensions for Olympic sprinters Asafa Powell and Sherone Simpson in 2013.",
      "mechanism": "Sympathomimetic amine that stimulates alpha and beta adrenergic receptors, causing vasoconstriction, increased heart rate, and blood pressure elevation.",
      "history": "Pharmaceutical drug in some countries at 16-40 mg doses. Found in supplements at up to 250 mg/day. Olympic sprinters Powell and Simpson suspended in 2013. FDA warning letters March 2016.",
      "whyBanned": "Dangerous cardiovascular effects including cardiac arrest. Supplements contain 6x pharmaceutical doses. Career-ending for athletes due to WADA ban.",
      "legalAlternatives": [
        "caffeine",
        "citrulline-malate"
      ],
      "metaTitle": "Methylsynephrine (Oxilofrine) - Cardiac Arrest Risk & Safe Alternatives",
      "metaDescription": "Methylsynephrine caused Olympic sprinter suspensions and 47 FDA adverse events including cardiac arrest. Learn the dangers and find safe alternatives.",
      "keywords": [
        "methylsynephrine",
        "oxilofrine",
        "methylsynephrine banned",
        "oxilofrine side effects",
        "methylsynephrine wada"
      ],
      "createdAt": "2025-01-27T00:00:00Z",
      "updatedAt": "2025-01-27T00:00:00Z"
    },
    {
      "id": "banned-hordenine",
      "slug": "hordenine",
      "name": "Hordenine",
      "alternativeNames": [
        "N,N-dimethyltyramine",
        "Anhaline",
        "Peyocactin"
      ],
      "category": "stimulant",
      "legalStatus": "restricted",
      "legalStatusDetails": "FDA Dietary Supplement Ingredient Advisory List. WADA prohibited stimulant. DoD Prohibited Dietary Supplement Ingredients List.",
      "bannedBy": [
        "WADA",
        "DoD"
      ],
      "stateRestrictions": {
        "US": "FDA Advisory List",
        "Sports": "WADA Prohibited",
        "Military": "DoD Prohibited"
      },
      "healthRisks": [
        {
          "category": "Regulatory",
          "description": "FDA states there is NO established safety evidence—even if an NDI notification were submitted, 'there is no history of use or other evidence of safety.'",
          "severity": "moderate",
          "sources": [
            "FDA Ingredient Advisory List"
          ]
        }
      ],
      "sideEffects": [
        "Increased heart rate",
        "Elevated blood pressure",
        "Anxiety",
        "Insomnia",
        "Jitters"
      ],
      "contraindications": [
        "Heart conditions",
        "Competitive athletes",
        "Military personnel",
        "MAO inhibitors"
      ],
      "overdoseRisk": "moderate",
      "addictionPotential": "low",
      "description": "Hordenine is a phenethylamine derivative found in bitter orange and barley. FDA added it to the Dietary Supplement Ingredient Advisory List stating there is NO established safety evidence. WADA prohibited and on DoD banned list for military personnel.",
      "mechanism": "MAO-B inhibitor and norepinephrine reuptake inhibitor. Prolongs effects of other stimulants and catecholamines.",
      "history": "Natural occurrence in barley and bitter orange. Added to FDA Advisory List. WADA and DoD prohibited.",
      "whyBanned": "No established safety evidence per FDA. WADA prohibited stimulant. DoD banned for military. Career-ending for athletes and military.",
      "legalAlternatives": [
        "caffeine",
        "l-tyrosine"
      ],
      "metaTitle": "Hordenine - WADA Banned, DoD Prohibited & Safe Alternatives",
      "metaDescription": "Hordenine has no established safety evidence per FDA. Banned by WADA and DoD. Find safe legal stimulant alternatives.",
      "keywords": [
        "hordenine",
        "hordenine banned",
        "hordenine wada",
        "hordenine dod",
        "hordenine side effects",
        "hordenine supplement"
      ],
      "createdAt": "2025-01-27T00:00:00Z",
      "updatedAt": "2025-01-27T00:00:00Z"
    },
    {
      "id": "banned-octopamine",
      "slug": "octopamine",
      "name": "Octopamine",
      "alternativeNames": [
        "Norsynephrine",
        "para-Octopamine",
        "β,4-dihydroxyphenethylamine"
      ],
      "category": "stimulant",
      "legalStatus": "restricted",
      "legalStatusDetails": "WADA prohibited stimulant. DoD Prohibited Dietary Supplement Ingredients List. FDA Dietary Supplement Ingredient Advisory List.",
      "bannedBy": [
        "WADA",
        "DoD",
        "FDA (advisory)"
      ],
      "stateRestrictions": {
        "US": "FDA Advisory List",
        "Sports": "WADA Prohibited",
        "Military": "DoD Prohibited"
      },
      "healthRisks": [
        {
          "category": "Regulatory",
          "description": "Listed on FDA Dietary Supplement Ingredient Advisory List. WADA prohibited. DoD banned. No established human safety data.",
          "severity": "moderate",
          "sources": [
            "FDA Advisory List",
            "WADA",
            "DoD OPSS"
          ]
        }
      ],
      "sideEffects": [
        "Increased heart rate",
        "Elevated blood pressure",
        "Anxiety",
        "Insomnia"
      ],
      "contraindications": [
        "Heart conditions",
        "Competitive athletes",
        "Military personnel",
        "MAO inhibitors"
      ],
      "overdoseRisk": "moderate",
      "addictionPotential": "low",
      "description": "Octopamine is a trace amine found in bitter orange. Despite natural occurrence, it's prohibited by WADA, DoD, and on FDA's Advisory List. Career-ending for competitive athletes and disqualifying for military personnel.",
      "mechanism": "Trace amine-associated receptor agonist and weak adrenergic agonist. Increases norepinephrine release.",
      "history": "Found naturally in bitter orange and invertebrates. Added to multiple prohibited lists due to stimulant effects and lack of safety data.",
      "whyBanned": "No established safety evidence. WADA prohibited. DoD banned. Career-ending for athletes and military personnel.",
      "legalAlternatives": [
        "caffeine"
      ],
      "metaTitle": "Octopamine - WADA & DoD Banned Stimulant & Safe Alternatives",
      "metaDescription": "Octopamine is banned by WADA and DoD despite being natural. Learn why it ends careers and find safe legal alternatives.",
      "keywords": [
        "octopamine",
        "octopamine banned",
        "octopamine wada",
        "octopamine supplement",
        "norsynephrine"
      ],
      "createdAt": "2025-01-27T00:00:00Z",
      "updatedAt": "2025-01-27T00:00:00Z"
    },
    {
      "id": "banned-n-methyltyramine",
      "slug": "n-methyltyramine",
      "name": "N-Methyltyramine",
      "alternativeNames": [
        "NMT",
        "4-hydroxy-N-methylphenethylamine"
      ],
      "category": "stimulant",
      "legalStatus": "restricted",
      "legalStatusDetails": "WADA prohibited stimulant. DoD Prohibited Dietary Supplement Ingredients List.",
      "bannedBy": [
        "WADA",
        "DoD"
      ],
      "stateRestrictions": {
        "Sports": "WADA Prohibited",
        "Military": "DoD Prohibited"
      },
      "healthRisks": [
        {
          "category": "Regulatory",
          "description": "WADA prohibited stimulant. DoD banned. Part of the bitter orange alkaloid complex with no established human safety.",
          "severity": "moderate",
          "sources": [
            "WADA",
            "DoD OPSS"
          ]
        }
      ],
      "sideEffects": [
        "Increased heart rate",
        "Elevated blood pressure",
        "Anxiety"
      ],
      "contraindications": [
        "Competitive athletes",
        "Military personnel",
        "Heart conditions"
      ],
      "overdoseRisk": "moderate",
      "addictionPotential": "low",
      "description": "N-Methyltyramine (NMT) is a phenethylamine found in bitter orange and barley. Prohibited by WADA and DoD. Part of the bitter orange alkaloid complex along with synephrine, octopamine, and hordenine.",
      "mechanism": "Trace amine that releases norepinephrine. Weak adrenergic effects.",
      "history": "Natural alkaloid in bitter orange. Prohibited by WADA and DoD due to stimulant classification.",
      "whyBanned": "WADA prohibited stimulant. DoD banned. Career-ending for athletes and military.",
      "legalAlternatives": [
        "caffeine"
      ],
      "metaTitle": "N-Methyltyramine - WADA & DoD Banned & Safe Alternatives",
      "metaDescription": "N-Methyltyramine is banned by WADA and DoD. Learn why this bitter orange alkaloid ends careers and find safe alternatives.",
      "keywords": [
        "n-methyltyramine",
        "nmt",
        "n-methyltyramine banned",
        "n-methyltyramine wada"
      ],
      "createdAt": "2025-01-27T00:00:00Z",
      "updatedAt": "2025-01-27T00:00:00Z"
    },
    {
      "id": "banned-cyclazodone",
      "slug": "cyclazodone",
      "name": "Cyclazodone",
      "alternativeNames": [
        "N-cyclopropylpemoline"
      ],
      "category": "nootropic",
      "legalStatus": "banned_usa",
      "legalStatusDetails": "Structural analog of pemoline (Schedule IV, withdrawn for hepatotoxicity). NEVER evaluated by FDA. WADA prohibited. Only appeared on market in 2017.",
      "bannedBy": [
        "FDA (unapproved)",
        "WADA"
      ],
      "stateRestrictions": {
        "US": "Unapproved Drug - Pemoline Analog",
        "Sports": "WADA Prohibited"
      },
      "healthRisks": [
        {
          "category": "Hepatotoxicity",
          "description": "Structural analog of pemoline, which was withdrawn in many countries due to liver failure and deaths. Cyclazodone has NEVER been evaluated for human use—safety is entirely unknown.",
          "severity": "high",
          "sources": [
            "Pemoline withdrawal data",
            "Research chemical emergence 2017"
          ]
        }
      ],
      "sideEffects": [
        "Presumed liver toxicity (pemoline analog)",
        "Insomnia",
        "Appetite suppression",
        "Anxiety",
        "Unknown long-term effects"
      ],
      "contraindications": [
        "Liver disease",
        "Anyone - completely untested"
      ],
      "overdoseRisk": "high",
      "addictionPotential": "moderate",
      "description": "Cyclazodone is a structural analog of pemoline—a Schedule IV drug WITHDRAWN in many countries due to fatal liver failure. Cyclazodone has NEVER been evaluated by FDA for human use. Safety information is entirely lacking. Only appeared on the research chemical market in 2017.",
      "mechanism": "Presumed dopamine reuptake inhibitor similar to pemoline. May share pemoline's hepatotoxicity mechanism.",
      "history": "Analog of pemoline (withdrawn for liver deaths). Appeared on research chemical market 2017. Zero human safety data.",
      "whyBanned": "Analog of hepatotoxic Schedule IV drug (pemoline). NEVER tested in humans. WADA prohibited. Zero safety data—essentially an experimental drug.",
      "legalAlternatives": [
        "caffeine",
        "l-theanine",
        "alpha-gpc"
      ],
      "metaTitle": "Cyclazodone - Untested Pemoline Analog & Why It's Dangerous",
      "metaDescription": "Cyclazodone is an analog of pemoline (withdrawn for liver deaths). NEVER tested in humans. Learn why it's dangerous and find safe alternatives.",
      "keywords": [
        "cyclazodone",
        "cyclazodone side effects",
        "cyclazodone liver",
        "cyclazodone pemoline",
        "cyclazodone reddit",
        "cyclazodone buy"
      ],
      "createdAt": "2025-01-27T00:00:00Z",
      "updatedAt": "2025-01-27T00:00:00Z"
    },
    {
      "id": "banned-hydrafinil",
      "slug": "hydrafinil",
      "name": "Hydrafinil (Fluorenol)",
      "alternativeNames": [
        "9-Fluorenol",
        "9-Hydroxyfluorene"
      ],
      "category": "nootropic",
      "legalStatus": "restricted",
      "legalStatusDetails": "Unscheduled but unregulated 'grey area' compound. WADA added as non-specified stimulant under S6.A effective January 1, 2025.",
      "bannedBy": [
        "WADA (effective 2025)"
      ],
      "stateRestrictions": {
        "Sports": "WADA Prohibited effective Jan 2025"
      },
      "healthRisks": [
        {
          "category": "Unknown",
          "description": "Unregulated research chemical with no human clinical trials. Added to WADA prohibited list effective 2025 under S6.A non-specified stimulants.",
          "severity": "moderate",
          "sources": [
            "WADA 2025 Prohibited List"
          ]
        }
      ],
      "sideEffects": [
        "Unknown - no clinical data",
        "Presumed eugeroic effects",
        "Insomnia",
        "Anxiety"
      ],
      "contraindications": [
        "Competitive athletes",
        "Unknown - no safety data"
      ],
      "overdoseRisk": "moderate",
      "addictionPotential": "low",
      "description": "Hydrafinil (9-Fluorenol) is an unregulated 'grey area' eugeroic compound related to modafinil. Zero human clinical data. WADA added it to the prohibited list effective January 1, 2025 as a non-specified stimulant.",
      "mechanism": "Eugeroic presumed to work similarly to modafinil. Actual mechanism unknown due to lack of research.",
      "history": "Research chemical with modafinil-like claims. Added to WADA prohibited list for 2025.",
      "whyBanned": "WADA prohibited effective 2025. No human safety data. Unregulated research chemical.",
      "legalAlternatives": [
        "caffeine",
        "l-theanine"
      ],
      "metaTitle": "Hydrafinil (Fluorenol) - WADA Banned 2025 & Safe Alternatives",
      "metaDescription": "Hydrafinil (9-Fluorenol) is now WADA prohibited as of 2025. Learn about this untested modafinil alternative and find safe legal options.",
      "keywords": [
        "hydrafinil",
        "9-fluorenol",
        "hydrafinil wada",
        "hydrafinil banned",
        "hydrafinil modafinil",
        "fluorenol"
      ],
      "createdAt": "2025-01-27T00:00:00Z",
      "updatedAt": "2025-01-27T00:00:00Z"
    },
    {
      "id": "banned-sulbutiamine",
      "slug": "sulbutiamine",
      "name": "Sulbutiamine",
      "alternativeNames": [
        "Arcalion",
        "Bisibuthiamine"
      ],
      "category": "nootropic",
      "legalStatus": "restricted",
      "legalStatusDetails": "FDA Dietary Supplement Ingredient Advisory List (December 2019). DoD Prohibited List. Prescription drug in France since 1973.",
      "bannedBy": [
        "FDA (advisory)",
        "DoD"
      ],
      "stateRestrictions": {
        "US": "FDA Advisory List",
        "Military": "DoD Prohibited",
        "France": "Prescription Only"
      },
      "healthRisks": [
        {
          "category": "Regulatory",
          "description": "Added to FDA's Dietary Supplement Ingredient Advisory List December 2019. DoD Prohibited. Not a legal dietary supplement in US.",
          "severity": "low",
          "sources": [
            "FDA Advisory List 2019",
            "DoD OPSS"
          ]
        }
      ],
      "sideEffects": [
        "Insomnia",
        "Anxiety",
        "Irritability",
        "Headache",
        "Nausea"
      ],
      "contraindications": [
        "Military personnel",
        "Bipolar disorder",
        "Anxiety disorders"
      ],
      "overdoseRisk": "low",
      "addictionPotential": "low",
      "description": "Sulbutiamine is a synthetic derivative of thiamine (vitamin B1) that crosses the blood-brain barrier. Prescription drug in France (Arcalion) since 1973 for asthenia. FDA added to Advisory List in 2019; DoD prohibited for military.",
      "mechanism": "Synthetic thiamine that crosses BBB. Increases thiamine and thiamine phosphate esters in the brain. May affect dopaminergic transmission.",
      "history": "Developed in Japan. Prescription drug in France since 1973 as Arcalion. FDA Advisory List 2019. DoD prohibited.",
      "whyBanned": "Not a legal dietary supplement per FDA Advisory List. DoD prohibited. Prescription drug status in other countries.",
      "legalAlternatives": [
        "alpha-gpc",
        "lions-mane"
      ],
      "metaTitle": "Sulbutiamine (Arcalion) - FDA Advisory & DoD Banned, Alternatives",
      "metaDescription": "Sulbutiamine is on FDA's Advisory List and DoD prohibited list. Learn about this prescription nootropic and find legal alternatives.",
      "keywords": [
        "sulbutiamine",
        "arcalion",
        "sulbutiamine banned",
        "sulbutiamine fda",
        "sulbutiamine dod",
        "sulbutiamine side effects"
      ],
      "createdAt": "2025-01-27T00:00:00Z",
      "updatedAt": "2025-01-27T00:00:00Z"
    },
    {
      "id": "banned-dendrobium",
      "slug": "dendrobium",
      "name": "Dendrobium Extract",
      "alternativeNames": [
        "Dendrobium nobile",
        "Shi Hu"
      ],
      "category": "stimulant",
      "legalStatus": "banned_usa",
      "legalStatusDetails": "FDA April 2014 warning letter established products labeled as dendrobium actually contained undeclared synthetic stimulants including DMAA and methamphetamine-like DEPEA.",
      "bannedBy": [
        "FDA"
      ],
      "stateRestrictions": {
        "US": "FDA Warning - Adulteration Cover"
      },
      "healthRisks": [
        {
          "category": "Adulteration",
          "description": "FDA investigation found products claiming 'dendrobium extract' actually contained UNDECLARED SYNTHETIC STIMULANTS including DMAA and N,α-diethylphenethylamine (DEPEA)—a methamphetamine-like compound.",
          "severity": "high",
          "sources": [
            "FDA Warning Letter to Driven Sports April 2014"
          ]
        }
      ],
      "sideEffects": [
        "Unknown - used as cover for synthetic stimulants",
        "Products may contain DMAA",
        "Products may contain methamphetamine analogs"
      ],
      "contraindications": [
        "Everyone - products are adulterated"
      ],
      "overdoseRisk": "high",
      "addictionPotential": "moderate",
      "description": "Dendrobium is an orchid extract used as a COVER for undeclared synthetic stimulants. FDA's April 2014 warning letter to Driven Sports found products labeled 'dendrobium' actually contained UNDECLARED DMAA and DEPEA (a methamphetamine-like compound). This demonstrated systematic supplement fraud.",
      "mechanism": "The orchid extract itself has minimal effects. Products labeled 'dendrobium' are used to hide illegal synthetic stimulants.",
      "history": "Traditional Chinese medicine orchid. Co-opted by supplement industry as cover for synthetic stimulants. FDA exposed fraud in 2014.",
      "whyBanned": "Used as fraudulent cover for undeclared synthetic stimulants including DMAA and methamphetamine analogs. Systematic supplement fraud.",
      "legalAlternatives": [
        "caffeine"
      ],
      "metaTitle": "Dendrobium Extract - FDA Exposed Stimulant Fraud & What to Know",
      "metaDescription": "FDA found 'dendrobium' supplements actually contained hidden DMAA and methamphetamine analogs. Learn about this supplement fraud.",
      "keywords": [
        "dendrobium",
        "dendrobium extract",
        "dendrobium pre workout",
        "dendrobium banned",
        "dendrobium dmaa"
      ],
      "createdAt": "2025-01-27T00:00:00Z",
      "updatedAt": "2025-01-27T00:00:00Z"
    },
    {
      "id": "banned-acacia-rigidula",
      "slug": "acacia-rigidula",
      "name": "Acacia Rigidula",
      "alternativeNames": [
        "Blackbrush Acacia",
        "Vachellia rigidula"
      ],
      "category": "stimulant",
      "legalStatus": "banned_usa",
      "legalStatusDetails": "FDA March 2016 warning letters determined Acacia rigidula is a New Dietary Ingredient. Products labeled as containing it actually contained synthetic stimulants like BMPEA and DEPEA.",
      "bannedBy": [
        "FDA"
      ],
      "stateRestrictions": {
        "US": "NDI Required - Products Adulterated"
      },
      "healthRisks": [
        {
          "category": "Adulteration",
          "description": "FDA established products labeled 'Acacia rigidula' actually contained SYNTHETIC STIMULANTS (BMPEA, DEPEA) that are NOT naturally present in the plant—systematic supplement adulteration.",
          "severity": "high",
          "sources": [
            "FDA Warning Letters March 2016",
            "FDA Research 2013"
          ]
        }
      ],
      "sideEffects": [
        "Unknown - used as cover for synthetic stimulants",
        "Products contain BMPEA (amphetamine analog)",
        "Products contain DEPEA (methamphetamine-like)"
      ],
      "contraindications": [
        "Everyone - products are adulterated"
      ],
      "overdoseRisk": "high",
      "addictionPotential": "moderate",
      "description": "Acacia rigidula is a Texas shrub used as FRAUDULENT COVER for synthetic stimulants. FDA scientifically proved that BMPEA and DEPEA are NOT naturally present in Acacia rigidula—they are synthetic adulterants with amphetamine-like effects. Systematic industry fraud.",
      "mechanism": "The plant itself has minimal pharmacological effects. Products labeled 'Acacia rigidula' are covers for illegal synthetic stimulants.",
      "history": "Native Texas shrub. Co-opted by supplement industry. FDA proved synthetic adulterants (BMPEA, DEPEA) are not naturally present in 2013-2016.",
      "whyBanned": "New Dietary Ingredient without notification. Used as fraudulent cover for synthetic amphetamine analogs. Industry-wide adulteration.",
      "legalAlternatives": [
        "caffeine"
      ],
      "metaTitle": "Acacia Rigidula - FDA Proved Synthetic Stimulant Fraud",
      "metaDescription": "FDA proved 'Acacia rigidula' supplements contain hidden synthetic amphetamine analogs, not natural plant extracts. Learn about this fraud.",
      "keywords": [
        "acacia rigidula",
        "acacia rigidula banned",
        "acacia rigidula bmpea",
        "acacia rigidula extract",
        "acacia rigidula side effects"
      ],
      "createdAt": "2025-01-27T00:00:00Z",
      "updatedAt": "2025-01-27T00:00:00Z"
    },
    {
      "id": "banned-arecoline",
      "slug": "arecoline",
      "name": "Arecoline (Betel Nut)",
      "alternativeNames": [
        "Betel nut",
        "Areca nut",
        "Areca catechu",
        "Paan",
        "Supari"
      ],
      "category": "other",
      "legalStatus": "restricted",
      "legalStatusDetails": "FDA Import Alert 23-15 detains all betel nut shipments. IARC/WHO classifies areca nut as Group 1 CARCINOGEN. California Proposition 65 listed.",
      "bannedBy": [
        "FDA (import alert)",
        "IARC/WHO (carcinogen)"
      ],
      "stateRestrictions": {
        "US": "FDA Import Alert",
        "California": "Proposition 65 Carcinogen"
      },
      "healthRisks": [
        {
          "category": "Cancer",
          "description": "IARC/WHO classifies areca nut as GROUP 1 CARCINOGEN (proven carcinogenic to humans). Pooled relative risk for oral cancer: 7.9x among chewers. One of the most carcinogenic substances known.",
          "severity": "high",
          "sources": [
            "IARC Monographs",
            "WHO",
            "California Prop 65"
          ]
        }
      ],
      "sideEffects": [
        "Oral cancer (7.9x risk)",
        "Oral submucous fibrosis",
        "Esophageal cancer",
        "Addiction",
        "Teeth staining",
        "Gum disease"
      ],
      "contraindications": [
        "Everyone - Group 1 carcinogen",
        "Pregnant women",
        "Children"
      ],
      "overdoseRisk": "low",
      "addictionPotential": "high",
      "description": "Arecoline from betel/areca nut is classified as a GROUP 1 CARCINOGEN by IARC/WHO—proven to cause cancer in humans. Chewing betel nut increases oral cancer risk by 7.9x. FDA detains all betel nut imports. One of the most carcinogenic substances with documented human evidence.",
      "mechanism": "Muscarinic acetylcholine agonist with stimulant and carcinogenic effects. Causes oral submucous fibrosis leading to cancer.",
      "history": "Traditional use in South/Southeast Asia. IARC classified as Group 1 carcinogen. FDA Import Alert active.",
      "whyBanned": "GROUP 1 CARCINOGEN—proven to cause cancer in humans. 7.9x oral cancer risk. FDA detains imports.",
      "legalAlternatives": [
        "caffeine"
      ],
      "metaTitle": "Arecoline (Betel Nut) - Group 1 Carcinogen, 7.9x Cancer Risk",
      "metaDescription": "Betel nut is a WHO Group 1 CARCINOGEN with 7.9x oral cancer risk. Learn why FDA detains all imports and find safe alternatives.",
      "keywords": [
        "arecoline",
        "betel nut",
        "areca nut",
        "betel nut cancer",
        "paan cancer",
        "supari cancer",
        "betel nut banned"
      ],
      "createdAt": "2025-01-27T00:00:00Z",
      "updatedAt": "2025-01-27T00:00:00Z"
    },
    {
      "id": "banned-synephrine",
      "slug": "synephrine",
      "name": "Synephrine",
      "alternativeNames": [
        "p-Synephrine",
        "Bitter orange extract",
        "Citrus aurantium"
      ],
      "category": "stimulant",
      "legalStatus": "restricted",
      "legalStatusDetails": "Complex status: Natural p-synephrine from bitter orange IS permitted. Synthetic p-synephrine HCl is NOT. WADA Monitoring Program (under surveillance). Note: Methylsynephrine (oxilofrine) is completely banned.",
      "bannedBy": [
        "WADA (monitoring)",
        "FDA (synthetic form)"
      ],
      "stateRestrictions": {
        "US": "Natural permitted, Synthetic banned",
        "Sports": "WADA Monitoring Program"
      },
      "healthRisks": [
        {
          "category": "Cardiovascular",
          "description": "Stimulant effects on heart rate and blood pressure. Natural form permitted but synthetic form banned. WADA monitoring for potential future prohibition.",
          "severity": "moderate",
          "sources": [
            "WADA Monitoring Program",
            "FDA"
          ]
        }
      ],
      "sideEffects": [
        "Increased heart rate",
        "Elevated blood pressure",
        "Headache",
        "Anxiety"
      ],
      "contraindications": [
        "Heart conditions",
        "Hypertension",
        "MAO inhibitors",
        "Other stimulants"
      ],
      "overdoseRisk": "moderate",
      "addictionPotential": "low",
      "description": "Synephrine has COMPLEX regulatory status: Natural p-synephrine from bitter orange fruit IS permitted in supplements. However, synthetic p-synephrine HCl is NOT permitted. WADA has synephrine in its Monitoring Program—under surveillance for potential future prohibition. Do NOT confuse with methylsynephrine (oxilofrine) which is completely banned.",
      "mechanism": "Alpha-adrenergic receptor agonist causing vasoconstriction and modest increases in metabolic rate and blood pressure.",
      "history": "Natural component of bitter orange. Complex regulatory status emerged. WADA monitoring. Distinct from banned methylsynephrine.",
      "whyBanned": "Synthetic form not permitted. WADA monitoring for potential ban. Athletes should avoid due to regulatory uncertainty.",
      "legalAlternatives": [
        "caffeine"
      ],
      "metaTitle": "Synephrine - Complex Legal Status, WADA Monitoring & What to Know",
      "metaDescription": "Synephrine has complex legal status: natural OK, synthetic banned, WADA monitoring. Learn the nuances and avoid career-ending mistakes.",
      "keywords": [
        "synephrine",
        "p-synephrine",
        "bitter orange",
        "synephrine banned",
        "synephrine wada",
        "synephrine legal",
        "citrus aurantium"
      ],
      "createdAt": "2025-01-27T00:00:00Z",
      "updatedAt": "2025-01-27T00:00:00Z"
    },
    {
      "id": "banned-dark-labs-crack-gold",
      "slug": "dark-labs-crack-gold",
      "name": "Dark Labs Crack Gold",
      "alternativeNames": [
        "Crack Gold Limited Edition",
        "Crack Gold 2025"
      ],
      "category": "stimulant",
      "legalStatus": "restricted",
      "legalStatusDetails": "2025 formula contains DMHA (FDA banned ingredient) but no longer contains DMAA. Gray market product sold primarily in Europe through authorized retailers. Not FDA-approved for sale in USA.",
      "bannedBy": [
        "FDA (DMHA ingredient)"
      ],
      "stateRestrictions": {
        "US": "Not legal - contains DMHA",
        "EU": "Gray market - varies by country"
      },
      "healthRisks": [
        {
          "category": "Cardiovascular",
          "description": "High-stimulant formula with 500mg total caffeine (300mg anhydrous + 200mg citrate) plus 250mg DMHA. Significant cardiovascular stress potential.",
          "severity": "high",
          "sources": ["Product Label Analysis"]
        },
        {
          "category": "Counterfeit Risk",
          "description": "Widespread counterfeiting reported, especially from unauthorized European distributors. Counterfeits may contain undisclosed or dangerous ingredients.",
          "severity": "moderate",
          "sources": ["Dark Labs Official", "Reddit User Reports"]
        }
      ],
      "sideEffects": [
        "Elevated blood pressure",
        "Rapid heart rate",
        "Extreme jitters",
        "Anxiety",
        "Insomnia",
        "Crash after effects wear off"
      ],
      "contraindications": [
        "Heart conditions",
        "Hypertension",
        "Stimulant sensitivity",
        "Under 18 years old",
        "Pregnancy"
      ],
      "overdoseRisk": "high",
      "addictionPotential": "moderate",
      "description": "Dark Labs Crack Gold is a high-stimulant pre-workout sold primarily in European gray markets. The 2025 formula contains DMHA (250mg), which is FDA-banned in the USA, along with approximately 500mg total caffeine. Unlike previous versions, the 2025 batch does NOT contain DMAA. Users report strong energy and focus but less 'euphoric hit' compared to older DMAA-containing formulas. Widespread counterfeiting is a major concern—only purchase from authorized retailers.",
      "mechanism": "Multi-stimulant blend: DMHA (250mg) acts as a sympathomimetic amine; caffeine anhydrous (300mg) + caffeine citrate (200mg) provide ~500mg total caffeine; Eria Jarensis (300mg) provides mood enhancement; Alpha Yohimbine (1.5mg) for fat mobilization.",
      "history": "Dark Labs is a European supplement brand known for aggressive stimulant products. Earlier Crack Gold versions contained DMAA until 2024. 2025 reformulation removed DMAA but retained DMHA. High counterfeit risk from unauthorized sellers.",
      "whyBanned": "Contains DMHA which FDA banned in 2019 as an unsafe food additive. Not legal for sale in USA. Gray market status in Europe.",
      "legalAlternatives": [
        "caffeine",
        "citrulline-malate",
        "beta-alanine",
        "alpha-gpc"
      ],
      "metaTitle": "Dark Labs Crack Gold 2025: Real vs Fake, Ingredients & Verification Guide",
      "metaDescription": "Complete guide to Dark Labs Crack Gold 2025: DMHA 250mg + 500mg caffeine formula, batch verification, counterfeit warnings, and safe legal alternatives.",
      "keywords": [
        "dark labs crack gold",
        "dark labs crack gold 2025",
        "dark labs crack gold review",
        "dark labs crack gold fake",
        "dark labs crack gold ingredients",
        "crack gold pre workout",
        "dark labs crack gold vs fake"
      ],
      "isProduct": true,
      "productBrand": "Dark Labs",
      "ingredients": [
        {"name": "L-Citrulline", "amount": "5000", "unit": "mg"},
        {"name": "Beta Alanine", "amount": "2000", "unit": "mg"},
        {"name": "Agmatine Sulfate", "amount": "1000", "unit": "mg"},
        {"name": "L-Tyrosine", "amount": "750", "unit": "mg"},
        {"name": "Alpha GPC 50%", "amount": "500", "unit": "mg"},
        {"name": "Caffeine Anhydrous", "amount": "300", "unit": "mg"},
        {"name": "Eria Jarensis Extract", "amount": "300", "unit": "mg"},
        {"name": "DMHA (Juglans Regia)", "amount": "250", "unit": "mg"},
        {"name": "Caffeine Citrate", "amount": "200", "unit": "mg"},
        {"name": "Halostachine", "amount": "50", "unit": "mg"},
        {"name": "Alpha Yohimbine", "amount": "1.5", "unit": "mg"}
      ],
      "authorizedRetailers": [
        "Official Dark Labs Store",
        "Predator Nutrition (UK)",
        "Cross The Limits (GB)",
        "Stay Focused (Germany)",
        "AmericanMuscleFit (Spain)",
        "Supplementhane (Turkey)"
      ],
      "counterfeitWarnings": [
        "Different lid/cap color than authentic product",
        "Blurry or faded labels with misaligned print",
        "Missing security seals or authentication codes",
        "Price significantly below €60",
        "Purchased from unauthorized dealers",
        "Batch code stickered rather than printed"
      ],
      "relatedPages": [
        {
          "slug": "dmaa",
          "title": "DMAA Complete Guide",
          "type": "banned",
          "relationship": "pillar"
        },
        {
          "slug": "dmha",
          "title": "DMHA (Octodrine)",
          "type": "banned",
          "relationship": "related"
        },
        {
          "slug": "banned-pre-workouts-2025",
          "title": "Banned Pre Workouts List 2025",
          "type": "article",
          "relationship": "related"
        }
      ],
      "createdAt": "2025-11-28T00:00:00Z",
      "updatedAt": "2025-11-28T00:00:00Z"
    },
    {
      "id": "banned-skull-labs-angel-dust",
      "slug": "skull-labs-angel-dust",
      "name": "Skull Labs Angel Dust",
      "alternativeNames": [
        "Angel Dust Pre-Workout",
        "Angel Dust V1",
        "Angel Dust V2"
      ],
      "category": "stimulant",
      "legalStatus": "banned_usa",
      "legalStatusDetails": "US version contains DMAA (100mg) and DMHA (100mg), both banned by FDA. Product is illegal for sale in the United States. EU version uses different formula without DMAA.",
      "bannedBy": [
        "FDA"
      ],
      "stateRestrictions": {
        "US": "Illegal - contains DMAA and DMHA",
        "EU": "Legal (EU version without DMAA)",
        "Germany": "Restricted"
      },
      "healthRisks": [
        {
          "category": "Cardiovascular",
          "description": "Extreme stimulant load: DMAA 100mg + DMHA 100mg + 300mg caffeine creates significant cardiovascular stress. Heart palpitations, rapid heart rate, and chest tightness commonly reported.",
          "severity": "high",
          "sources": ["FDA DMAA/DMHA Warnings", "User Reports"]
        },
        {
          "category": "Neurological",
          "description": "Users report extreme jitters, tremors, anxiety, and panic-like symptoms. Severe energy crashes after effects wear off.",
          "severity": "moderate",
          "sources": ["User Experience Reports"]
        }
      ],
      "sideEffects": [
        "Extreme jitters and tremors",
        "Rapid heart rate and palpitations",
        "Anxiety and panic feelings",
        "Dry mouth",
        "Niacin flush (skin redness)",
        "Beta-alanine paresthesia (tingling)",
        "Severe energy crash",
        "Insomnia",
        "Chest tightness"
      ],
      "contraindications": [
        "Heart conditions",
        "Hypertension",
        "Anxiety disorders",
        "Stimulant sensitivity",
        "Under 18 years old",
        "Pregnancy"
      ],
      "overdoseRisk": "high",
      "addictionPotential": "moderate",
      "description": "Skull Labs Angel Dust is an extreme high-stimulant pre-workout with two distinct versions: the US version containing DMAA (100mg) + DMHA (100mg) + Caffeine (300mg), and the milder EU version without DMAA. The US version represents one of the strongest pre-workouts available but is illegal in the United States due to banned DMAA/DMHA content. The V2 reformulation is reportedly weaker than the original V1, with user complaints about reduced potency and 'bunk' batches.",
      "mechanism": "Triple stimulant stack: DMAA (100mg) as norepinephrine releasing agent; DMHA (100mg) as sympathomimetic amine; Caffeine (300mg) as adenosine antagonist. Combined with pump agents (Agmatine 1500mg, Citrulline 1000mg) and mood enhancers (Eria Jarensis 200mg, Beta-phenylethylamine 700mg).",
      "history": "Skull Labs is a US-based brand with European distribution. Original V1 formula was extremely potent with high DMAA content. V2 reformulation drew user complaints about reduced efficacy. EU version uses different formula to comply with regulations.",
      "whyBanned": "Contains DMAA (100mg) and DMHA (100mg)—both FDA-banned dietary supplement ingredients. Illegal for sale in USA. Products sold online are not FDA-compliant.",
      "legalAlternatives": [
        "caffeine",
        "citrulline-malate",
        "beta-alanine",
        "alpha-gpc",
        "l-theanine"
      ],
      "metaTitle": "Skull Labs Angel Dust: US vs EU Ingredients, V1 vs V2 & Side Effects [2025]",
      "metaDescription": "Complete guide to Skull Labs Angel Dust: US version (DMAA 100mg + DMHA 100mg), EU version differences, V1 vs V2 changes, side effects, and legal alternatives.",
      "keywords": [
        "skull labs angel dust",
        "skull labs angel dust ingredients",
        "skull labs angel dust review",
        "angel dust pre workout",
        "skull labs angel dust dmaa",
        "skull labs angel dust v2",
        "skull labs angel dust us vs eu"
      ],
      "isProduct": true,
      "productBrand": "Skull Labs",
      "ingredients": [
        {"name": "Beta-Alanine", "amount": "2500", "unit": "mg"},
        {"name": "Agmatine Sulfate", "amount": "1500", "unit": "mg"},
        {"name": "Citrulline Malate", "amount": "1000", "unit": "mg"},
        {"name": "Creatine Nitrate", "amount": "1000", "unit": "mg"},
        {"name": "Arginine AKG", "amount": "1000", "unit": "mg"},
        {"name": "Beta-Phenylethylamine", "amount": "700", "unit": "mg"},
        {"name": "Choline Bitartrate", "amount": "500", "unit": "mg"},
        {"name": "Caffeine Anhydrous", "amount": "300", "unit": "mg"},
        {"name": "Eria Jarensis Extract", "amount": "200", "unit": "mg"},
        {"name": "DMHA", "amount": "100", "unit": "mg"},
        {"name": "DMAA", "amount": "100", "unit": "mg"},
        {"name": "Higenamine HCL", "amount": "50", "unit": "mg"},
        {"name": "Hordenine HCL", "amount": "50", "unit": "mg"},
        {"name": "N-Methyl L-Tyramine", "amount": "50", "unit": "mg"},
        {"name": "Niacin", "amount": "25", "unit": "mg"},
        {"name": "GABA", "amount": "25", "unit": "mg"},
        {"name": "Yohimbe Extract", "amount": "2", "unit": "mg"},
        {"name": "Alpha Yohimbine", "amount": "2", "unit": "mg"}
      ],
      "relatedPages": [
        {
          "slug": "dmaa",
          "title": "DMAA Complete Guide",
          "type": "banned",
          "relationship": "pillar"
        },
        {
          "slug": "dmha",
          "title": "DMHA (Octodrine)",
          "type": "banned",
          "relationship": "related"
        },
        {
          "slug": "banned-pre-workouts-2025",
          "title": "Banned Pre Workouts List 2025",
          "type": "article",
          "relationship": "related"
        }
      ],
      "createdAt": "2025-11-28T00:00:00Z",
      "updatedAt": "2025-11-28T00:00:00Z"
    }
  ]
}